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Abstract
CHARACTERIZATION OF A CYTOTOXIN FROM
CAMPYLOBACTER JEJUNI
AND ITS ROLE IN PATHOGENICITY
by
Sangeeta Mahajan
University of New Hampshire, May 1990

Campylobacter jejuni is a major cause worldwide of human gastroenteritis. In this
study, the pathogenicity of the organism was examined in fertile hens' eggs and the
mortality data and histopathological findings induced by both the organism and bacteriafree filtered broth were similar. The absence in chick embryo tissues of either bacteria or
an inflammatory infiltrate suggested a toxic etiology. A protein was obtained from the
filtrate by gel electroelution and this was sensitive to heat, pH changes and trypsin
treatment and was lethal for the fertile hen's egg. It showed cytotoxic effects in primary
chick embryo fibroblast (PCEF), Chinese hamster ovary (CHO) and intestinal 407 (Int
407) cells. Subsequently, a 68 kilodalton protein was isolated by polyacrylamide gel
electrophoresis from the eluted toxic protein (ETP). A monoclonal antibody (CETPMAty)
raised to the ETP abolished toxicity and bound only to the 68 kilodalton protein. No
homology between £ . jejuni ETP and Vibrio cholerae toxin and their respective antisera
was observed. In enzyme-linked immunosorbent assay (ELISA) tests, the ETP did not
bind to GMi ganglioside. Binding of ETP to PCEF and Int 407 host cell membranes was
maximal after 2 h and this adherence was significantly reduced by prior treatment of the
x ii i

cells with proteolytic enzymes, neuraminidase or glutaraldehyde but not with Bgalactosidase, lipase, Nonidet P-40 or sodium metaperiodate. In competitive binding
assays, sugars (except N-acetyl neuraminic acid), lectins or GMi ganglioside did not
adversely influence uptake of the ETP by these cells. Electron microscopic examination of
the Int 407 cells treated with either £ . jeiuni or ETP showed similar ultrastructural damage.
Western blot and ELISA tests of bacterial sub-components probed with CETPMAhj
indicated that the toxin was associated with the outer membranes of the organism.
Immunoassays on ETP treated eukaryotic host cells demonstrated that the toxin was
attached only to the cell membranes and was not internalized. The present study indicates
that the production of a membrane adhering cytotoxin that binds to protein or glycoprotein
receptors on host cell membranes may be an important virulence factor responsible for the
inflammatory diarrhea caused by many £ . jejuni strains.

xiv

INTRODUCTION
1.1 Historical Perspective:
The members of the genus Campylobacter (Greek meaning 'curved rod') are
associated with a wide variety of diseases in humans and animals. These vary from
enteritis to ulcers. Not only are these organisms one of the leading causes of
gastroenteritis, but they are also the main etiologic agents of enzootic sterility in cattle and
abortion in various domestic animals. The potential of these vibrio-like organisms to cause
disease was first reported in 1913 by McFadyean & Stockman (95), who found them to be
the cause of abortion in cattle and sheep. Smith (135) isolated similar organisms from an
aborted bovine fetus. They were characterized by Smith & Taylor (136) and given the
name Vibrio fetus. In 1931, Jones et al. (59) reported an association of these organisms
with winter dysentery in cattle. To investigate the reproducibility of the disease, they fed
pure cultures of these vibrios isolated from diseased animals to healthy cattle. The jejunum
was the first site in the intestinal tract to be infected and they proposed the name Y- ieiuni as
it resembled Y- fetus sufficiently to be regarded as a closely related group. Doyle (31)
linked these organisms to another disease after isolating them from the colonic mucosa of
hogs with swine dysentery. The name Y- coli was proposed.
Levy (83) reported the first case of human infection and raw milk was suspected as
the source of the outbreak. As the cultures were lost on subculture, it was Vinzent et al.
(156) who reported the first definitive human infection by these vibrios. The organism,
subsequently named Y fetus , was isolated from the blood and placenta of a pregnant
woman suffering from fever, headache, influenza-like symptoms who delivered a still bom
fetus. King (67) differentiated two distinct groups of vibrios from blood cultures of
infected humans based on their ability to grow at different temperatures. She noted that Y1

fetus grew at 25*C and 37*C but not at 42*C whereas the other group of organisms which
were identical to the Y- jejuni of Jones et al. and the Y- Cfili of Doyle could not grow at
25*C but only at 37’C or 42*C.
Surprisingly after this very few cases o f related vibrio infections were reported until
1972. The major problem was the lack of a selective culture technique for the isolation of
these organisms from fecal samples. The breakthrough came when Dekeyser et al. (29)
developed a procedure to isolate these microaerophilic vibrios from stool samples. The
genus by then had been renamed by Sebald & Vdron (129) as Campylobacter. Their
technique involved nitration of the stool suspensions through a 0.65 Jim membrane filter.
Butzler et al. (21) used this technique but the isolation rate was low. However, Sldrrow
(130) isolated Campvlohacter vibrios, using a selective culture medium. He plated the
stool samples directly on Blood agar base 2 supplemented with 7% lysed horse blood, 10
mg/1 vancomycin, 2500IU/L polymyxin B and 5 mg/L trimethoprim. George et al. (40)
reported that 0.25% each of ferrous sulfate, sodium metabisulfite and sodium pyruvate
(FBP) added to the broth or agar increased the aerotolerance of Campvlohacter. Karmali
and Fleming (63) developed a method to isolate these organisms horn stools based on the
principle of Fortner. They streaked a rapidly growing Proteus species on one half of the
agar plate which reduced the oxygen tension, enabling Campylobacter to grow on the other
half. Butzler and Skirrow (22) and Gilchrist et al. (41) developed other selective media
containing different concentrations of vancomycin, trimethoprim, polymyxin B and
cephalothin for the isolation of Campylobacter. The result was that even small laboratories
were able to perform routine isolations of this organism and this led to much work on the
disease potential of these bacteria. Subsequently it was shown that these organisms were
isolated from diarrheal stool samples at a rate comparable to the salmonellae.
1.2 D isease:
a)

Clinical Presentation: Campylobacter ieiuni. an enteropathogenic organism, is
2

now recognized as the leading cause of diarrhea worldwide. The symptoms of £ . ieiuni
infection are summarized in Table 1. At the mild end of the spectrum, the symptoms only
last for 24 h and are then indistinguishable from those of viral gastroenteritis. However, in
severe cases, the patients may have an elevated temperature leading to confusion and
delirium. This prodromal state may last for 2 days followed by nausea and abdominal
cramps. These symptoms are rapidly followed by profuse diarrhea which may be watery
or may have fresh blood. Inflammatory exudates containing polymorphs have been
observed in some fecal samples examined microscopically. Vomiting, though rare, may
occur in some cases. The acute diarrhea lasts for approximately 3 days. Several reports
have shown that profuse watery diarrhea is a common feature in patients in developing
countries. In some cases this leads to sufficient dehydration and electrolyte imbalance to
require hospitalization of the patient. However, the illness usually does not last longer than
one week. The presence of blood, pus and mucus in the stools of patients suggests
colorectal inflammation. Colgan et al. (26) reported 10 of 11 patients they studied had
colitis while Lambert et al. (78) found that 70% of their patients had colon inflammation
and Blaser et al. (17) reported colitis in all of their patients. Campylobacter infections can
lead to several severe complications including inflammatory bowel disease (102). Some
patients develop erythema nodosum (77) or reactive arthritis following Campylobacter
enteritis. Urinary tract infection (28) and the Guillain-Barri syndrome (61) due to £ . jeiuni
have also been reported. This organism may also cause meningitis (44,103,151).
b)

Treatment: Use of chemotherapy for diarrhea is somewhat controversial. For

most intestinal infections, antimicrobial agents are considered ineffective and may be
disadvantageous. Campylobacter enteritis is usually a mild self-limiting disease. The
patient recovers in 1 or 2 days when given antibiotics while in the absence of therapy, the
stools can be positive for 2-5 weeks. The drug of choice for £. jejuni infection is
erythromycin (33). This agent is relatively non-toxic, has a narrow spectrum and shortens
3

TABLE 1

CLINICAL PRESENTATION OF CAMPYLOBACTERIOSIS
CAUSED BY £ . JEJUNI

Symptoms

% incidence1
Adults

Children

watery diarrhea or loose stools

61

84

bloody stool

3.6

52

fever and malaise

47

76

severe abdominal pain

47

58

rectal pain

10

51

nausea or vomiting

2.6

32

reactive arthritis

38

2

»: data compiled from references number 14,18,23 and 112 and 157.

4

the fecal excretion of £. jejuni (113). However, strains resistant to erythromycin and
tetracycline have been reported (145,147,150).
In cases of illness accompanied with severe abdominal pains or complications,
antibiotics are necessary. Fluid and electrolyte replacement is often required for infants and
children. In vitro, the most active drugs are furazolidone, doxycycline, chloramphenicol
and aminoglycosides but the organism is resistant to penicillin G, cephalosporin and
trimethoprim (150,154). Aminoglycosides are recommended for septicemic patients while
the use of chloramphenicol is limited due to the serious side effects of this drug. In
developing countries, Campylobacter enteritis is a more serious infection compared with
developed countries and factors such as low socioeconomic status and malnutrition might
explain the severity of infection.
1.3 Epidemiology of C. ieiuni:
a)

Reservoirs: C. jejuni occurs as a commensal in the intestinal tract of a wide

variety of wild and domestic animals. It has been reported in cattle (57), sheep (134),
poultry (45,107), several species of wild birds (88), and pets including dogs (16,99) and
cats (16,140). In the U. S., a majority of chicken carcasses sold at retail markets are
contaminated with £ . jejuni (45,107) and contamination of raw poultry products can be as
high as 89% and seems to be seasonal with a peak in the summer months (52,108). This
organism appears to be a normal commensal of cows but is an important cause of epizootic
infectious abortions in sheep (134), although occasionally it may exist as a long term
intestinal commensal without morbidity. Studies on non-human primates have shown that
Campvlohacter infection is common (125, 153). In short, most animals in frequent contact
with humans including those used for food or those that are domestic pets are reservoirs for
Campylobacter. Besides a wide variety of living hosts, this organism is often found in
water and its presence may be due to fecal contamination by wild or domestic animals and

5

birds. In United States, it has been isolated from streams, rivers (70) sea water (71) as
well as mud and sewage sludge (106).
b)

Incidence & Prevalence: £ . jejuni is an important cause of diarrhea in

developed as well as developing countries of the world. The magnitude of infection is
difficult to assess as the fecal samples obtained are only a fraction of the people actually
having acute diarrheal illnesses. Campylobacter infections have been reported to the
Communicable Disease Surveillance Center in England since 1977. For the year 1980, the
reported annual isolation rate was about 21/100,000 and for 1981, with approximately
12,500 Campylobacter isolations made, this rate rose to 28/100,000 (65). A demographic
survey in 1987 of Campylobacter. Salmonella and Shigella infections in England made by
Skirrow (131) showed the maximum isolation rate for the campylobacteria was 5.5% while
that for the salmonellae was 3.4% and shigellae was 0.8%. In these studies it was shown
that infection with this organism showed a peak incidence in children under 5 years of age
and adults between the ages of 15 to 24 years (65,131). In a study done in France,
39,000 stool specimens were examined for £ . jejuni over a two year period (112) and a
total of 231 strains of £. jejuni were isolated from 172 patients. Infected symptomatic
patients had diarrhea (54%), abdominal pain (32%), nausea (15%) and rectal pain (18%).
In United States, the national reporting started in the early 1980's. Studies
conducted in different localities showed that infection by this organism was as common as
Salmonella or Shigella infections. In a five year survey conducted from 1982 to 1986 by

the Center for Disease Control (142) 1,343 isolates of Campvlohacter were reported of
which 99% were represented by £. jejuni (Fig 1). A two year study of 2670 fecal samples
from patients with gastro-intestinal illness in Denver showed an isolation rate of 4.6% for
Campvlohacter. The rate of stool positivity was highest during summer and lowest in

winter (13). It is the most common enteric pathogen reported among travellers returning
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Figure 1: Average incidence of Campylobacter jejuni cases reported to the Center for
Disease Control from 1982-1986 (142). Note the higher incidence during the summer
months of each year.

with acute diarrheal illness from developing countries (138). In developed countries, it
appears that there is a bimodal distribution of Campvlnhacter infection by age with the
highest incidence in infants and in persons 15-24 years of age. However, in developing
countries where hygiene conditions are poorer, the prevalence of infection is highest in
young children (14,18,115). In an epidemiologic study conducted in Bangladesh in 1980
(14), £ . ieiuni was isolated from 14% of the patients registered in the hospital surveillance
system. It was isolated more frequently than Shigella species (12%) and was the third
highest detected pathogen after enterotoxigenic Escherichia coli (20%) and rotavirus (19%).
However, among the people registered in the village surveillance system, 54% were found
to have £ . jejuni infection. It seems that infection in Bangladesh is endemic and the
organism is found commonly both in patients with diarrhea and in healthy control subjects.
In a survey of healthy people in South India in 1981, the infection was found to be
prevalent in all age groups (115). In Mexico during the year 1988, £ . jejuni infections had
a peak annual incidence of 3.5 episodes/child for individuals between the ages of 12-17
months and this incidence declined to 0.6 episodes/child for 5 year olds (23).
c)

Modes of transmission: £. jejuni may be transmitted from its animal reservoir

to humans in a number of ways but the most common route is through the ingestion of
contaminated food or water. Raw or undercooked poultry is perhaps the major vehicle for
food-borne Campvlohacter enteritis (139). In different parts of the world, ingestion of
poorly cooked chicken, hamburgers, turkey and even cake icing have resulted in illness
(11,13). In England and Wales, unpasteurized milk is the most frequent source of £.
ieiuni. Between 1978 and 1980,13 outbreaks due to consumption of unpasteurized milk
were reported (60,114,118,119). Robinson (117) reported that consumption of 500
bacterial cells in milk was enough to cause illness and the organisms have been found to be
viable in milk for up to 3 weeks (15). The major source of this organism is thought to be
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from fecal contamination of milk by the cow, though bovine mastitis cannot be ruled out
(79).
Several large outbreaks of enteritis have been traced to drinking water. In 1978, an
outbreak of Campylobacter involving 3000 people or 19% of the residents occurred in
Bennington, Vt (137). Another outbreak in Sweden involved an estimated 2000 people
(97) and the source of contamination was found to be surface water that had entered the
municipal water system which had been insufficiently chlorinated. This organism has been
isolated from both salt and fresh water sources in places where humans have acquired the
infection (71). £. jejuni can remain viable for weeks in water maintained at 4*C (13).
Person to person transmission of this organism is not common. Most infections
due to £ . jejuni are associated with mild enteritis but bacteremia in pregnant women may
lead to a severe systemic infection in the fetus (46). Neonatal meningitis has been repealed
in a 12 day old boy and £ . jejuni was isolated from cerebrospinal fluid (151). The mother
had diarrheal illness 6 weeks before delivery.
1.4 Pathogenesis of the organism:
£ . jejuni, recently established as an agent of human gastroenteritis, is recognized as
one of the most frequently isolated bacterial species causing infectious diarrheal disease
(10, 81,138). Although the disease has a world-wide distribution, it is particularly severe
in the developing countries (14,23,115). Due to lack of a suitable animal model for the
study of this organism, the mechanisms of pathogenesis have yet to be established.
Current evidence suggests that disease follows either colonization, tissue invasion and/or
toxin production by £. jejuni strains (158). Indeed, the many factors may account for the
wide spectrum of symptoms following infection with this organism.
Recovery of vast numbers of bacteria from stools indicates that it efficiently
colonizes and multiplies in the human gut Organisms have been observed adjacent to the

mucosal epithelium and the crypts of the small intestine in chicken (122) and mice (37).
Most strains show poor adhesion to epithelial cell lines like HeLa and Intestinal 407 cells
(92). However, using a mouse cecal model, Lee etal. (82) suggested that mucus
colonization in the absence of adhesion is a prelude to intestinal infection. Systemic
invasion of the blood and extraintestinal organs has been documented in humans (8,69,
81) though the incidence is low. In experimentally infected calves (2) and chickens (22,
122), there is a transient systemic spread of the organism. An invasive nature for the
organism has been shown by various workers (35, 36,81,101); however, strains are
uniformly negative in the Sereny test (92) suggesting a lack of invasiveness.
The induction of secretory diarrhea points towards the production of toxin(s) by
this organism. Ruiz-Palacios et al. (124) were among the first to report the production of
an enterotoxin by £ . ieiuni and since then reports of an enterotoxin (68,84,94) and a
cytotoxin (48, 111, 161) have been made. Various eukaryotic cell lines including MRC-5,
Hep 2, Chinese hamster ovary (CHO) and Veto cells as well as a number of animal model
systems have been used for toxigenicity studies (5,48,58,161). The nature and mode of
action of the toxin(s) remains controversial.
A further mechanism characteristic of Salmonella and Yersinia species, by which
this organism is thought to cause disease, is termed translocation. In this, the organism
penetrates the intestinal mucosa but results in minimal damage and proliferates in the lamina
propria and mesenteric lymph nodes (22,130). It has been suggested by workers (158)
that translocation might be the mechanism by which this organism causes disease and the
bloody dysentery and watery diarrhea may represent the two ends of the clinical
presentation. The prevalence and significance of bacteremia associated with £. jejuni
enteritis is controversial. Kiehlbauch etal. (66) demonstrated that £ . ieiuni can survive
intracellularly in blood monocytes in vitro for up to 7 days, leading to the suggestion that
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phagocytosis may facilitate the survival of this organism.
It remains to be determined whether the variability in the disease presentation is due
to inherent differences among different strains of Q. jejuni or to the host responses.
However, it is likely that variations in symptoms may result from different pathogenic
mechanisms predominating for different strains, such as is seen for the various types of £.
£Qli1.5 Im m une response to C. ieiuni infection:
The relative importance of humoral and cell-mediated immunity in resistance to
campylobacteriosis has not yet been delineated; however various epidemiological studies
suggest that immunity against Q. jejuni is acquired as a result of infections in humans. In
Bangladesh, the age-related increase in anti-Campylobacter serum IgA titers noted among
children and young adults appears to be the best indicator of Q. jejuni immunity (9,42).
The evidence for acquisition of immunity has been substantiated in studies using human
volunteers where it was shown that the individuals who were previously challenged with
the organism did not become ill on subsequent exposure to Q. ieiuni (8). Blaser et al. (12)
reported that raw milk drinkers have elevated levels of IgG antibody but normal levels of
IgM and IgA antibodies to £ . ieiuni. On the other hand, patients with diarrhea have high
antibody titers for all three types but while the IgA titer falls to normal levels rapidly, the
titers of IgG and IgM antibodies remain high reaching normal levels only after about 90
days. Individuals with known IgA immunodeficiencies have been reported to have
problems recovering from Campylobacter enteritis (91).
Similar experiments in animals have resulted in protection against the organism after
rechallenge (20,123). Both Burr etal. (20) and Ruiz-Palacios et al. (123) found that
animals that had been challenged by the removable intestinal tie adult rabbit diarrhea
(RITARD) process were protected during the second RITARD challenge. Abimiku and
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Dolby (1) demonstrated that immune mammary secretion strongly protects against intestinal
colonization by this organism in natural and fostered infant mice. A high concentration of
IgG antibody specific for £. jejuni was found in the serum and mammary secretion of
vaccinated dams. However, the duration of this protective immunity to rampvlnharrer
species and its association to antibody response is yet to be reported in both animals and
humans.
1.6 Taxonomy and nomenclature of the genus Campylobacter:
Nowhere in the area of campylobacteria work is there more confusion than in its
nomenclature. Until 1963, when Sebald and Vdron (129) proposed the name
;, these microaerophilic organisms were included in the genus Vibrio.
However, based on the microaerobic nature of the bacteria, their inability to ferment or
oxidize carbohydrates and difference in their G+C ratio (133) as compared with the Vibrio
species, they were assigned to a different and new genus.
This genus comprises 14 species, recently reviewed by Penner (110). For many
years it had been convenient to divide this genus into pathogenic and non-pathogenic
species based on catalase production (54,64). However, this grouping became less
relevant after the discovery of non-pathogenic, catalase positive species, £. crvaerophila
and £ . nitrofigilis. Catalase negative or weak strains were first isolated from dogs by
Sandstedt etal. (127) and DNA hybridization studies showed that they belonged to a
separate species. Although yet to be officially designated, they have been called £.
upsaliensis (121.127).
£ . fetus contains two subspecies due to the high degree of relatedness by DNA
hybridization and identical protein profiles; subsp. fetus and subsp. venerealis (51,65). £ .
ieiuni is considered a separate species rather than a subsp. of C. fetus (134). Recently
hippurate positive, nitrate negative isolates of Campylobacter have been recovered from
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adult human gastric biopsy and feces of children with diarrhea and are considered a subsp.
of £ . jejuni (137). It is suggested that the species should be subdivided into £. jejuni
subsp. ieiuni and £. jejuni subsp. doylei. It is the only hippurate positive species of this
genus (S3) and can be differentiated from £ . coli based on this test, though the two are
currently grouped together. These two can be further divided into several biotypes based
on the scheme proposed by Lior (85) (Table 2). £. hvointestinalis was isolated from
lesions of proliferative ileitis in pigs (39). It closely resembles £. fetus except that it
produces H2S in TSI medium and can grow anaerobically in 0.1% trimethylamine N-oxide
hydrochloride. £ . laridis was isolated from sea gulls in 1980 and differs from £. jejuni by
its resistance to nalidixic acid (132). It was originally referred to as nalidixic acid resistant,
thermophilic Campylobacter till the species name £. laridis was proposed in 1983 by
Benjamin et al. (6). £. concisus was isolated from human periodontal disease in 1981
(141).
£ . sputorum. a non-pathogenic species, has been of little or no clinical significance
and is comprised of three biovars or biotypes, biovar sputorum. biovar bubulus and biovar
fecalis. The oxidase positive, catalase negative species £ . mucosalis was for sometime
considered a subsp. of £. spuroram but due to differences in DNA relatedness it was
assigned to a separate species (121). The discovery of £. pylori may prove one of the
most exciting developments in microbiology in the last decade. Although not yet
conclusive, there is evidence that these urease positive bacteria are responsible for gastric
ulcers. There is much controversy with regard to its nomenclature as it seems to be more
closely related to the genus Wolinella than to Campylobacter (120). It was recently
proposed that £ . pvlori be transferred to a new genus Helicobacter as the organism differs
in ultrastructure, morphology, fatty acid composition and growth characteristics from the
genus Wolinella (43).
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TABLE 2

BIOTYPING SCHEME FOR CAMPYLOBACTER IEIU NI
AND CAMPYLOBACTER COLI»

Tests
I

C. ieiuni
II
IB

IV

C. coli
i n

Hippurate hydrolysis

+

+

+

+

-

Rapid H2S test

-

-

+

+

-

DNA hydrolysis

+

■ : Proposed by Lior in 1984 (85).

14

-

+

-

+

According to the Bergey's Manual of Systematic Bacteriology, the genus Campvinhartgr
comprises only 5 species. However, following the isolation of newly recognized
organisms, which has led to a rapid expansion in the number of putative members of this
genus, the taxonomy and nomenclature of this group is in flux. Those organisms within
the group are listed in Table 3 along with proposed alternative nomenclature.
1 .7

M o r n h n l o y i e a l c h a r a c t e r is t ic s o f C . i e i u n i :

The organisms belonging to this genus are slender, nonsporing S-shaped rods
approximately 0.2 to 0.5 pm wide and 1.5 to 3.5 pm long with tapering ends (80,134).
Electron microscopic studies have revealed that different morphological forms exist within
different parts of the same colony (76). At the periphery cells are spiral while in the center
the cells are mostly coccus-shaped. These coccoid cells are usually found to be nonviable on subculture. The organisms are motile with their characteristic darting corkscrewlike motion by means of a single polar flagellum (134). The unsheathed flagella are
approximately 21 nm in diameter and range from 2.6 to 3.9 pm in length (109). A recent
study by Han et al. (50) reported the presence of sheathed flagella in £ . cinnaedi and £ .
fenneliae which makes them closely related to £. pvlori (H. pylori!. Other adherence
appendages like fimbriae and pili have not been observed on £. ieiuni. Virtually all
members of this genus are oxygen sensitive and require oxygen tension to grow.
The outer cell membrane has a wave-like morphology and is a highly asymmetric
lipid bilayer that loosely fits over the cell wall. SDS-PAGE profiles reveal that the outer
membrane of £. ieiuni contains 7 major polypeptide bands (86) of which the 43-kilodalton
protein comprises almost 70% of the membrane protein content and is thought to be a
porin. Hie 68-kilodalton protein has been found to be temperature dependent and its
molecular weight increases when the incubation temperature of the organism is altered from
37*C to 42*C (93). The LPS is of low molecular weight and lacks long repeating O15

TABLE 3

TAXONOMY AND BIOHEMICAL CHARACTERISTICS OF THE GENUS CAMPYLOBACTER
Catalase

Species
C. jejuni
spp. jejuni
spp. dovlei
C. coli
£ . fetus
spp. fetus
spp. Ycncccalis
C. sputorum
biovar sputorum
biovar bubulus
biovar fecalis
C. concisus
C. hvointestinalis
C. laridis
C. m ucosalis
C. crvaeroDhila
C. niirofieilis
C. unsaliensis
C. ovlori*
C. cinaedi*
C. fennelliae*

+
+/+

h 2s
Nitrate Hippurate Nalidixic
onTSI
acid

-

+
+

_

m

+
+
+
+
+
+
?
-

-

+
-

+
+
+
+
+
+
+

-

-

“

Cephalothin

Growth (*C)
25 37 42

G+C content
(mol%)

+
+

+
+
-

S
S
s

R
S
R

.

-

+
+
+

+
+/+

30-32
29-30
31-33

+
+

_

R
R

S
S

+
+

+
+

_

33-34
33-34

+
+
+
+
+
+
+
+
+
V
+
•

-

S
R
R
R
R
R
R
V
S
S
R
S
S

S
s
s
R
s
R
s
R
S
S
S
I
S

-

-

-

“

-

+
+
+
+
-

_

+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
-

31-32
31-32
32-33
38-39
35-36
31-33
38-39
29-30
28-29
35-36
36-37
37-38
37-38

+ : Positive reaction/growth; -: Negative reaction/ no growth; +/-: 10% to 90% strains are positive;
?: not known; V : Variable reaction; R : Resistant; S ; Sensitive; I : intermediate zones of inhibition
* = A new genus, Helicobacter has been proposed for the three strains £ . pylori. £ . cinaedi and £• fennelliae .

antigen side chains (86). It contains L-glyceio-D-manno-heptose, glucose, galactose, and
glucosamine. The fatty acids present are mainly 3-hydroxy-tetradecanoic acid, 3-deoxy-Cmanno-octulosonic acid and n-hexadecanoic acid (98). In some Gram-negative species, the
outer membrane is released during growth in the form of 'blebs' or vesicles. Electron
microscopic examination of £. ieiuni has revealed distinct outer membrane blebbing (80,
109). Protein profiles of the blebs showed them to be similar but not identical to the outer
membrane; however, the major outer membrane protein is present (80).
A loose fitting cell wall encloses the asymmetrically election-dense cell membrane.
The periplasm separates the outer and cell membrane. Hie cytoplasm is a compact matrix
consisting of evenly dispersed ribosomes and a fine skein of nuclear material. The
cytoplasm is occasionally traversed by dark staining clefts and membrane-bound
osmiophilic granules or laminated structures approximately 50 to 75 nm in diameter are
found in the cytoplasm of some cells (80). In Q. fetus a 97-kilodalton glycoprotein forms a
microcapsule which may afford some protection to the organism from phagocytosis (160).
No such antiphagocytic surface protein is seen in £ . jejuni. The organisms belonging to
this genus are unable to accumulate PHB granules in the cytoplasm, which differentiates
them from the genus Spirillum.
1.8 Biochemical properties o f the organism :
£. jeiuni is a next spore forming, microaerophilic, Gram-negative, non-acid fast
organism. It is unable to utilize carbohydrates and has a strictly respiratoiy type
metabolism (134). These organisms derive energy chiefly from amino acids and
intermediates of the tricarboxylic acid (TCA) cycle. Hoffman e tal. (55) found this
organism to respire with formate, succinate, lactate, malate, glyoxylate, glutamate,
oxaloacetate, pyruvate, acetate, fumarate and a-oxoglutarate, though oxidation of formate
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and hydrogen are thought to be the prime sources of energy and growth. Both formate
dehydrogenase and hydrogenase are located in the periplasm (56). Respiratory activities
detennined with membrane vesicles are 50 to 100 fold higher with formate and hydrogen
than with succinate, malate, or NADH as substrate. The stoichiometry of respiratory
driven proton translocation (H+/0) is 2 for all substrates except hydrogen (H+/0 = 3.7) and
formate (H+/0 = 2.5) (56). Addition of nitrate, aspartate or fumarate does not allow strains
of £ . jejuni to grow anaerobically as they do for the subspecies of Q. fetus. Even though
£ . ieiuni produces menaquinones in the same manner as bacteria capable of respiring nitrate
or fumarate, the organism is unable to use this election carrier to transfer electrons to nitrate
or fumarate under anaerobic conditions (155). They do not possess lipase and cannot
hydrolyze gelatin, urea, casein, ribonucleic acid, deoxyribonucleic acid or esculin (133).
The presence of cytochromes in Campylobacter species has been demonstrated and these
are chiefly of the b- and c- type, being associated with a complex terminal oxidase system
(24,55,56). The respiratory chain of £ . jejuni is partially sensitive to inhibitory effects of
2-heptyl-4-hydroxyquinone-N-oxide (HQNO), which is used to determine the entry point
of electrons into the electron transport chain (55).
A microaerobic environment is required for the growth of £. jejuni and a
concentration of 5% oxygen and 10% carbon dioxide is determined as optimal, while 21%
oxygen is bacteriostatic (134). The microaerophilic nature of this organism is due to a high
sensitivity to exogenously generated superoxide anions and hydrogen peroxide even
though superoxide dismutase and catalase are present in the cell (55). Carbon monoxide
has little inhibitory effect on respiration except under very low oxygen tension (56).
George et al. (40) described an FBP supplement that neutralizes the toxic derivatives of
oxygen if added to the basal medium. Moreover, these iron salts and dihydroxy phenyl
compounds, known to bind iron, are assumed to alleviate the iron deficiency of this
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organism. All enzymes essential for activity in the presence of oxygen contain or require
iron for their activity. Norepinephrine, a dihydroxy phenyl compound has been shown to
stimulate iron uptake (55).
1.9 Phvsico-chemicaL properties of C.ieiuni:
The growth o f £ . ieiuni in laboratory culture media is restricted to temperatures
above 32*C and below 45*C. The optimal temperature for growth is 42*C though it grows
well at 37‘C. In foods this organism survives better at 4*C than at room temperature (15).
Christopher cLal- (25) reported that £ . jejuni cells do not survive heating in skim milk at
60*C for 1 min. Hence a typical pasteurization process of heating at 62*C for 30 min is
sufficient to free the food products of this organism. The optimum pH for growth is 7.3 7.5 though it can grow in media with pH between 6.0 to 8.0 (25). The organism can grow
in the presence of 1.5% sodium chloride but 2.0% is inhibitory (32).
1.10 Genetics of th e organism:
One of the powerful methods for understanding the pathogenesis of a
microorganism is the genetic analysis of the determinants that contribute to its virulence.
The relatively recent recognition of £ . jejuni as a pathogen and its microaerophilic nature
have limited our knowledge in this area. Plasmids have been shown to specify virulence
traits like adherence, invasiveness, antimicrobial resistance and toxin production in a
variety of pathogens. Although workers have shown plasmids in £ . ieiuni. till now only
antimicrobial resistance has been found to be plasmid encoded (3,19). Erythromycin and
ampicillin resistance in £ . iejuni has been shown to be specified by chromosomal genes,
while tetracycline resistance is plasmid encoded (143,145,147,148). Tetracycline
resistance is transmissible within the genus Campylobacter but all attempts to
transconjugate it into £ . £&Uhave failed (146,148). However, thetef gene has been
cloned and introduced into several strains of £. coli (150). Using a guinea pig model,
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Taylor and Bryncr (144) showed that pathogenicity in £ . jejuni and £. coli is not plasmid
mediated.
Enterotoxins from £. coli have been shown to be plasmid coded (49), but the tet
resistance plasmid does not encode either cytotoxin or enterotoxin activity in £ . jejuni as
originally thought (149). Although toxin production may be encoded on some plasmid or
the chromosome, the other virulence factor studied with respect to genetic control is the
flagellum. Newell et al. (101) fed mice with mixtures of Fla+ and Fla- strains and
recovered only Fla+ strains from the feces. In a similar study Black etal. (8) observed that
in human volunteers fed with both flagellated and non-flagellated strains, only the
flagellated strains were isolated from their stool samples. A bidirectional switch in the
expression of flagella has been observed in some strains.
A group of researchers working with an independently isolated kanamycin
tetracycline resistant plasmid has suggested that their kanamycin resistance determinant may
be translocated in £ . jejuni (73). Identification of a transposon in Campylobacter would
definitely have a great impact on the genetic studies of this genus.
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MATERIALS AND METHODS
Techniques used to study pathogenesis of Campylobacter ieiuni
2.1 Origin and maintenance of the bacteriaL strains:
Seven strains of Campylobacter jejuni isolated from fecal samples of patients with
acute gastroenteritis or diarrhea (Table 4) were passaged once on buffered charcoal yeast
extract (BCYE) agar medium at 37*C for 48 h in an atmosphere of 10% CO2 and 5% O2.
These were identified as £• ieiuni based on morphological and biochemical rests including
Gram stain, motility, catalase, oxidase, hippurare hydrolysis, oxidation of carbohydrates
and growth at 25*C and 42’C (Table 3). They were subsequently maintained at -70*C in
10% serum with 1% sorbitol. These strains were biotyped by the method described by
Lior (85) which separates the organism into different types based on three rests: hippurate
hydrolysis, rapid H2S production and DNA hydrolysis (Table 2).
2.2 Production and concentration of crude toxin from Campylobacter ieiuni:
Thawed samples of the seven strains were used to inoculate 100 ml of thioglycolate
broth (pH 7.3) and these were grown microaerobically at 37*C to a density equivalent to
approximately 5 x 107 to 4 x 108 colony forming units (cfu) /ml. Cell-free filtrates were
obtained by filtration through a 0.22 pm-pore-size membrane filter.
For further purification o f the crude toxin, £ . jejuni strain WD 2483 was used to
inoculate thioglycolate broth in 1-liter batches and these were grown microaerobically as
described. The final bacterial concentration ranged between 5 x 107 and 4 x 108 cfu/ml.
The bacteria-free supernatants were obtained by centrifugation of broth grown organisms at
15,300 x g using a Beckman J2-21M Induction drive centrifuge (Beckman Instruments,
Inc., Palo Alto, CA) for 10 min at 4*C followed by filtration through a 0.22 pm pore-size
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TABLE 4

SOURCE AND HISTORY OF THE STRAINS USED IN THE
STUDY

Strains

Specimen

Clinical condition

WD 2483

fecal sample

gastroenteritis

Wentworth Douglass Hospital, Dover, NH

WD2914

fecal sample

gastroenteritis

Wentworth Douglass Hospital, Dover, NH

WD2920

fecal sample

gastroenteritis

Wentworth Douglass Hospital, Dover, NH

WD2939

fecal sample

gastroenteritis

Wentworth Douglass Hospital, Dover, NH

M AI

fecal sample

diarrhea

Mt. Auburn Hospital, Boston, MA

MA2

fecal sample

diarrhea

Mt. Auburn Hospital, Boston, MA

BS 1

fecal sample

gastroenteritis

Bay State Medical Center, Springfield, MA

22

Origin

membrane filter. The filtrate was concentrated 50-fold in a rotary evaporator (model
R110, Brinkmann Instruments Inc., Westbury, NY). The concentrate was dialyzed against
phosphate buffered saline (PBS) pH 7.3 using 6 to 8 kilodaltons molecular mass cut off
Spectrapor # 1 cellulose dialysis tubing (Spectrum Medical Industries, Inc.. Los Angeles,
CA) and further concentrated to one-sixth its volume using polyethylene glycol (molecular
weight IS to 20 kilodaltons) (PEG) by the method of Whitby and Rodgers (159). The
sample was then dialyzed in PBS overnight at 4'C and the protein concentration determined
by the method of Lowry e ta l. (87).
2.3 E ee type, and determ ination of LDci>:
Antibiotic-free, fertile White Leghorn hens' eggs were obtained from the UNH
Poultry Farm, and incubated in a humid atmosphere at 36‘C. Thawed samples of strain
WD 2483 were grown on the bacteriological media and the bacteria were washed from the
surface of the agar and suspended in 5 ml of phosphate buffered saline (PBS), pH 7.3, to
give an optical density equivalent to 109 cfu/ml as determined by a Klett Summerson
photoelectric colorimeter. Bacterial density data were confirmed by colony counts on
BCYE agar.
Organisms were introduced into eggs by four inoculation routes: allantoic cavity
and chorio-allantoic membrane at 10 days of embryo incubation, amniotic and yolk sac at 6
days of embryo incubation (Fig 2 and 3). Serial 10-fold dilutions of £ . jejuni strain WD
2483 were made in PBS, with organism number equivalents ranging from 101 to 107
cfu/ml. Samples of 0.1 ml of each dilution were inoculated into 10 eggs by each of the
inoculation routes. Eggs were incubated and candled twice daily to record embryo
viability. In order to develop a reproducible assay for pathogenesis as determined by the
induction of disease, the LDso for each inoculation route was determined by the method of
Reed and Muench (116). Experiments for each route were done three times and the LDso
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Figure 2: Schematic diagram of developing chick embryo showing the allantoic, ammodc
and yolk sac routes of inoculation.
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Chorio-allantoic membrane route

False air sac

Air displaced
from sac

Figure 3: Schematic diagram of the chorio-allantoic membrane route of inoculation in the
chick embryo. (For labels see figure 2).

calculations averaged.
Similar 10-fold dilutions of the unconcentrated bacterium-free filtered broth,
originally containing approximately 5 x 107 to 4 x 10* cfu/ml of the seven strains prior to
organism removal, were made and 0.1 ml injected into the yolk sacs of fertile eggs. For
each dilution 10 eggs were used and these were candled twice daily and embryo mortality
was recorded.
2.4 Preparation and maintenance of cell cultures:
The cell culture media used are described in detail in Appendix 2. All media were
warmed to 37*C before use and the cells were incubated in 5% CO2 at 37*C. The three cell
cultures used in this study were primary chick embryo fibroblast (PCEF) cells, human
intestinal 407 (Int 407) cells and Chinese hamster ovary (CHO) cells,
a)

Prim ary chick embrvo fibroblast (PCEF) cells: Embryos from 10 day old

fertile hens' eggs were removed aseptically and placed in a sterile petri dish. The head,
wings and legs were removed and the torso was rinsed in Hank's balanced salt solution
(HBBS). The torso was chopped with sterile scissors into approximately 1 mm3 cubes and
the minced tissue was aseptically transferred to a trypsinizing flask containing a stirring bar
and 10 ml of a 0.1% trypsin solution. Trypsinization proceeded at room temperature for 10
min and the supernatant was poured through a sterile silk filter into a 50 ml centrifugation
tube containing a few drops of calf serum. The cell suspension was maintained cold by
keeping the tube in crushed ice. Care was taken not to lose any of the minced tissue. A
further 10 ml of trypsin was added and trypsinization allowed to proceed for another 20
min. The trypsin-tissue mixture was filtered into the centrifugation tube as described and
subjected to centrifugation for 10 min at 175 x g. The supernatant fluid was decanted and
the pellet resuspended in 2 ml of nutrient media (Eagle's minimum essential media (MEM)
supplemented with 200 mM glutamine (10 ml/L), 7.5% sodium bicarbonate (29.4 ml/L)
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and 10% fetal bovine serum). Cells were seeded in T-25 cm2 flasks (Costar Corporation,
Cambridge, MA) at a density of 10* cells/ml and grown to confluent monolayers. The
monolayers were trypsinized using trypsin-EDTA (0.05%-0.02%) and the cells
redistributed at a density of 10* cells/well in 6 well plates (Costar, Cambridge, MA), each
well of which contained a glass coverslip. When the fibroblast cells formed an almost
confluent monolayer, the growth media was replaced with maintenance media containing
1% serum and the plates were ready for inoculation.
b)

Human Intestinal 407 (Int 4071 cells: Epithelial Int 407 cells, derived from

the jejunum and ileum of a two month old Caucasian embryo, were obtained from the
ATCC (Rockville, MD) and were maintained in Eagle's MEM supplemented with 7.5%
sodium bicarbonate (29.4 ml/L), 200 mM glutamine (10 ml/L) and 10% new bom calf
serum. The cells were grown in T-75 cm2 flasks at 37*C in a CO2 incubator to give
confluent monolayers. These were trypsinized using 2 ml of trypsin-EDTA (0.05%0.02%) and the cells were redistributed in 96 well plates (cell density 102 cells/well) and 6
well plates containing glass coverslips (cell density 10* cells/well) and grown to give
confluent monolayers for subsequent use in binding, IFA, and cytotoxic studies. Prior to
all inoculations, the growth media was replaced with maintenance media.
c)

Chinese ham ster ovarv (CHOI cells: CHO cells, an epithelial cell line

derived from the ovary of an adult Chinese hamster, were obtained from ATCC and grown
in T-75 cm2 flasks in Eagle's MEM supplemented with 200 mM glutamine (10 ml/L),
7.5% sodium bicarbonate (29.4 ml/L) and 10% new bom calf serum at 37*C in a CO2
incubator. Confluent monolayers were resuspended using 2 ml of trypsin-EDTA and
distributed in 6 well plates containing glass coverslips (cell density 10* cells/well). When
cells were in confluent monolayers the growth media was replaced with maintenance media
containing 1% serum and they were used to establish the nature of the C. ieiuni toxin.
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2.5 Polvacuvlamide eel electrophoresis (PAGE) and immunoblotting:
Gel electrophoresis was used for the isolation and purification of the toxin as well
as for the analysis of protein profiles of the cellular fractions of strain WD 2483 and the Int
407 cells. The reagent formulations used are given in Appendix 5. Preparative, non
denaturing, discontinuous, PAGE was performed using a modification of the procedure by
Davis (27). A 10% separating gel and a stacking gel containing 5% aciylamide in 0.125 M
tris (pH 6.8) was used. Electrophoresis was performed at 30 mA. For identification, the
protein bands were stained with 0.1% Coomassie Blue R 250 (Sigma Chemical Co., St.
Louis, MO.).
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was
performed under reducing conditions by the procedure previously described by Laemmli
(75). The separating gel contained 10% acrylamide solution and 0.2% SDS on 0.35 M
Tris hydrochloride buffer (pH 8.8) while the stacking gel contained 5% acrylamide solution
and 0.1% SDS in 0.125 M Tris hydrochloride buffer (pH 6.8). The running buffer was
0.025 M Tris hydrochloride-0.192 M glycine with 0.1% SDS. Electrophoresis was
performed at 30 mA. The proteins were silver stained by the method of Oakley (105).
Each gel contained molecular weight standards (BioRad, Richmond, Ca).
Electrophoretic transfer of the proteins from polyacrylamide gels on to
nitrocellulose paper was accomplished by Western blot technique (152). Typical transfer
conditions were 100 mA constant current for 18-24 h in a Trans-Blot transfer cell
(BioRad). Nitrocellulose membranes were then equilibrated in Tris buffered saline pH 7.5
(TBS) for 30 min. Unoccupied sites on the nitrocellulose were blocked by incubating the
blots in 3% gelatin-TBS for 30-40 min. Immunoblots were washed twice in TBS and then
incubated for 1 h at room temperature in the primary antisera (mouse monoclonal or rabbit
polyclonal antibodies, see section 2.11). After washing in TBS, the blots were incubated
in either goat anti-mouse or goat anti-rabbit-horseradish peroxidase conjugate (Organon
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Teknika Corp., Malvern, PA) as appropriate, each diluted 1:2000 in 1% gelatin-TBS.
All immunoblots were developed in 4-chloro-l-naphthol (BioRad). Substrate
buffer was made by dissolving 60 mg of 4-chloro-1-naphthol in 20 ml of ice cold methanol
which was then added to TBS containing 0.015% H202- The reaction was stopped by
rinsing the blots in distilled water followed by TBS.
2.6 Enzyme-linked immunosorbent assay fELISAl:
ELISA was used for the various binding studies and was performed in 96 well
plates. The preparation and formulation of the various reagents used in ELISA are
described in Appendix 4. The wells were coated with the GMi ganglioside, cell
monolayers, or cellular fractions depending on the study involved. They were washed
with PBS and post coated with 0.3 ml of 3% bovine serum albumin. These were washed
three times with 0.5% Tween 20 in PBS (T-PBS) and 100 |il of primary antibody
(monoclonal or polyclonal) was added to each well. The plates were incubated at 37*C for
2 h and after three washes with T-PBS, 100 pi of goat anti-mouse or goat anti-rabbithorseradish peroxidase conjugate was added for 1 h. After three washings with T-PBS,
3, 3', 5 ,5'-tetramethyl benzidine substrate was added to each well and the reaction stopped
with 2 M sulphuric acid. The color intensity was read using an EIA reader (Whittaker MA
bioproducts, Walkersville, MD) at 405 nm.
2.7 Indirect immunofluorescence assay (IFA):
After histological processing of infected chick embryo organs (see section 2.9),
deparaffinized tissue sections and tissue homogenates as well as eukaryotic cell monolayers
that had been treated with bacteria or toxin for binding assays were fixed in 10% buffered
formalin for 2 h and washed in PBS. They were subsequently treated with a 1:10 dilution
of polyclonal antibody raised to Q. jejuni strain WD 2483 or the monoclonal antibody to
the ETP for 1 h at 37*C. Unbound globulin was removed with three washings in PBS.
Cells or tissues were then treated with a 1:200 dilution of goat anti-rabbit or goat anti
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mouse fluorescein isothiocynate (Fl'l'C) conjugated antibody (Organon Teknika Corp.) for
1 h. Unbound globulin was removed by washing in PBS and the tissue sections,
homogenates or the cell monolayers on coverslips were mounted in 1% 1,4 - diazobicyclo
(2.2.2) octane (DABCO) (Sigma) and viewed with an Olympus BH-2 epifluorescence
microscope.
2.8 Electron microscopy:
The reagents used for electron microscopy, both transmission and scanning, are
described in detail in Appendix 6.
a)

Preparation of samples: After treatment with £ . ieiuni strain WD 2483 or its

isolated toxin Int 407 cells were washed twice in HBSS and fixed in 5% (v/v)
glutaraldehyde in 0.05 M sodium cacodylate containing 10 mM MgS04 for 1 h. Fixed
monolayers were rinsed ten times in cacodylate buffer, scraped from the plastic surface
with a rubber policeman, collected by centrifugation and pro-embedded in 2% (w/v) Noble
agar. Cubes of 1mm3 thickness were cut and post fixed in 1% osmium tetroxide (OSO4) in
cacodylate buffer for 1 h.
b)

Resin embedding: Post fixed samples were washed in cacodylate buffer

followed by a ethanol dehydration series for 5 min in each of 50%, 70%, 90%, and 95%
ethanol in cacodylate buffer and twice for 10 min in absolute alcohol. Care was taken to
prevent the samples from drying during these steps. After alcohol dehydration, samples
were rinsed in propylene oxide. The resin used for embedding was an Epon-Araldite mix.
To allow complete resin infiltration, samples were placed in a 2:1 mixture of propylene
oxide and resin for 1 h and then in 1:2 mixture of propylene oxide and resin for another
hour. This was replaced with complete resin for 1 h and then by degassed resin for another
hour. Specimens were transferred to embedding blocks using a wooden swab stick
sharpened at one end and the blocks filled with degassed resin. Great care was taken to
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prevent the introduction of air bubbles in the resin. Blocks were polymerized in an oven at
60'C for 24 h and left at room temperature for a further 24 h to allow complete hardening to
occur.
c)

Thin sectioning: Blocks were trimmed using an LKB Ultratome III

ultramicrotome with glass knives made on an LKB knife maker. Thin sections were cut
with a diamond knife using the thermal advance on the ultramicrotome. Ribbons of grey
and silver sections (approx. 30-90 nm thickness) were picked up on 400 mesh copper grids
and the grids with sections on them were blotted dry using a piece of filter paper. All
materials in contact with the sections including the knife, water, and grids were stringently
cleaned so as to completely exclude dust and grease.
d)

Staining: Sections were stained with 5% uranyl acetate for 1 min and washed

thoroughly with boiled double distilled water using 20 ml per grid. The grids were then
stained with 0.4% lead citrate for 20 sec and washed again with 40 ml of boiled double
distilled water. Sections were blotted with filter paper and allowed to dry. Stains were
made fresh for each use and filtered through a 0.2 |im filter before use. Sections were
examined by transmission electron microscopy (TEM) in a Hitachi H 600 electron
microscope at 75 kV and photographed.
e)

Scanning Electron Microscopy (SEMI: For SEM, confluent cell monolayers

grown in 6 well plates with glass coverslips were similarly inoculated with £ . ieiuni strain
WD 2483 or its toxin and the samples were treated in the same way as described above up
to and including the dehydration in the graded ethanol series. The coverslips with the
monolayers were further rinsed in absolute alcohol and critical point dried using liquid CO2
in a Samdri-790 (Tousimis Research Corp., Rockville, MD). Prior to examination,
samples were coated with 12 nm of gold palladium with a target to specimen distance of 5
cm at a current of 15 mA for 4 min in a Hummer V Sputter Coater.
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The Organism
2.9 Histonathologv of C. ieiuni in chick embrvo:
Inoculum doses of strain WD 2483 equivalent to 10,100 and 1000 times the yolk
sac LD50 were made in PBS. Each multiple dose LD50 was inoculated into the yolk sacs of
fertile eggs (30 eggs per multiple dose) and the embryos were harvested daily up to 8 days
post-inoculation. Organs of the control as well as the experimentally treated eggs including
liver, heart, kidney, spleen and the gastro-intestinal (GI) tract were removed and fixed in
buffered 10% formalin. Fixed organs were embedded in paraffin wax in a Lab Tek tissue
processor (Miles Laboratories Inc., Naperville, 111.) and trimmed using a razor blade. Four
micron thick sections were cut with an American Optical rotary microtome, deparaffinized
and stained with hematoxylin and eosin as described in Appendix 1. Organs from similarly
treated eggs were removed aseptically for bacterial colony counts. They were rinsed in
PBS, weighed, homogenized in a Sorval Omni Mixer, serially diluted and 0.1 ml portions
were plated on BCYE agar. Deparaffinized tissue sections and formalin fixed tissue
homogenates were incubated with rabbit anti-£. jejuni serum and FTTC-conjugated goat
anti-rabbit serum for immunofluorescence studies as described earlier.
Pathological changes induced by the cell-free filtered Q. jejuni strain W D 2483 were
assayed by inoculation of 0.1 ml of a 1:100 dilution of the filtrate originally containing 5 x
107 cfu/ml into the yolk sac of the eggs. As described previously, organs of the inoculated
eggs were harvested and the different tissue sections were analyzed for any histological
changes. Samples of filtrates from all seven £. ieiuni strains were subjected to a 15-min
exposure to 60*C or 100*C, changes in pH using 1 N HCI or 1 N NaOH, or treated with
0.5 mg/ml each of trypsin XI, protease XIV and lipase I for 30 min. The residual toxic
activity was assayed after these treatments by inoculation into the yolk sac of fertile hens'
eggs.
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2.10 Isolation and biochemical characterization of the toxin from C. ieiuni:
Approximately 2 ml of the concentrated, dialyzed bacterium-free filtrate (described
in section 2.2) together with an equal volume of sample buffer (10% glycerol in 0.08 M
tris, pH 6.8) was loaded on a 1.5 mm thick preparative, non-denaturing, discontinuous
polyacrylamide gel. A 10% separating gel and a 5% stacking gel were used as described in
section 2.5. For identification, the protein bands were stained with 0.1% Coomassie Blue
R 250 (Sigma) and similar unstained bands were cut from the gels and individually eluted
in an Elutrap apparatus (Schleicher & Schuell). Each eluant was filter sterilized and tested
for toxicity by inoculation into the yolk sacs of 6 day old fertile Leghorn hens' eggs. The
eluted toxic protein (ETP) was subjected to SDS-PAGE and the gel was silver stained
(105) to reveal the proteins. Each gel contained molecular weight standards (BioRad).
As for the bacterium-free filtrate, the ETP was also subjected to 15 min treatments
of 60*C or 100*C, to changes in pH, to freeze-thawing, or to treatment with 0.5 mg/ml
each of trypsin, protease and lipase for 30 min. The toxic activity of the ETP was assayed
after these treatments by inoculation into the yolk sac of fertile hens' eggs.
2.11 Preparation of antibodies:
Specific antibodies are needed for the various assays performed in this study like
ELISA, IFA, immuno-electron microscopy, Western blots and the neutralization assays.
For this reason polyclonal antibody against £. jejuni strain WD 2483 and monoclonal
antibody against its toxin were raised as described.
a)

P n lv r lo n a l a n t ib o d y ;

£ . jejuni polyclonal antibody to strain WD 2483 was

prepared in white New Zealand rabbits. The organisms (10* cfu/ml) were fixed in 1%
buffered formalin containing some sterile egg yolk. These formalin-fixed organisms were
mixed with an equal volume of Freund's incomplete adjuvant and injected into the flanks of
rabbits by 30 sub-dermal injections using a 21-gauge needle. Further immunizations were
given after two and four weeks. Two weeks after the final inoculations, the rabbits were
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anesthetized with 50 mg of Pentobarbital Sodium (Nembutal) injection in the peripheral
vein of the ear and exsanguinated by cardiac puncture. Serum was examined for antibody
specificity by both neutralization of chick embryo lethality assays and immunofluorescence
of whole organisms using goat anti-rabbit FTTC conjugate (Organon Teknika Corp.).
b)

Monoclonal antibody fMAbl; MAb was raised against the ETP from Q . jejuni

strain WD 2483 using a modification of the procedure by Galfinf and Milstein (38). The
media formulation used in the preparation is given in Appendix 3. Two Balb/c mice were
primed by intraperitoneal injection with 1 to 5 pg of ETP in increasing doses in Freund's
incomplete adjuvant (Sigma) over eight weeks. The spleens of the primed mice were
removed aseptically, washed in serum free media and cut into small fragments. The spleen
suspension was then aspirated and expelled using a 20 ml syringe with a 18-gauge needle
to break up clumped cells. NS-1 mouse myeloma cells were used for fusion with spleen
cells and were grown as confluent monolayers in T-75 cm2 flasks. A total of 6 x 107 NS-1
cells were fused with 10* spleen cells using warm polyethylene glycol. The fused cells
were suspended in RPMI-1640 cell culture media containing 10% hypoxanthine, 1%
aminopterin and 10% thymidine (HAT medium) and 0.1 ml was distributed into 96 well
plates at a concentration of 5 x 10* spleen cells/well. The plates were incubated at 37*C in
5% CO2. The medium in the plates was changed after 4 days and care was taken not to
allow the medium to evaporate. Positive wells were identified using a microtiter mirror.
They appeared as white "spotches" in the bottom of a well.
Clones producing ETP specific MAb were selected by incubating 100 ill of the
medium from each well with ETP at a protein concentration of 10 ng. After incubation at
37*C for 30 min the mixtures were inoculated into fertile hens' eggs for lethal assay. The
ability of the MAb to neutralize the toxic potential of the toxic filtrates from the other 6
strains was similarly assayed by egg inoculation. The specificity of the MAb for the ETP
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was further confirmed by transfer of the ETP to nitrocellulose by Western blot techniques,
as described in section 2.5.
2.12 Cvtonathic affect of C. ieiuni on eukaryotic cells:
Thawed samples of £ . jejuni strain WD 2483 were harvested from BCYE agar
plates. They were washed in HBSS and suspended in maintenance media that contained
1% serum at a concentration of approximately 5 x 108 cfu/ml. The confluent monolayers
of PCEF cells in individual wells of 6 well plates (2-3 x 106 cells/well) and were inoculated
with the bacterial suspension at a multiplicity of infection (MOI) of 100 bacteria to 1
eukaryotic cell for up to 36 h. These experiments were repeated using Int 407 cells at a
similar cell density and bacterial inoculum. The monolayers were examined twice daily for
any cytopathic and cytolytic affects.
2.13 U ltrastructural changes in Int 407 cells induced bv C. jejuni:
Int 407 cells inoculated with £. jejuni strain WD 2483 at a MOI of 100:1 were
harvested at 2 ,6,12 and 24 h post infection and prepared for electron microscopic
examination. Infected and control cell monolayers were examined using electron
microscopy as described in section 2.8. Briefly, samples were rinsed in 0.05 M cacodylate
buffer, fixed in 5% glutaraldehyde, post fixed in 1% OSO4, dehydrated in a graded ethanol
series, embedded in epon-araldite, thin sectioned and the sections examined in a Hitachi H
600 electron microscope.
For SEM, the cell monolayers were similarly treated as far as dehydration in
ethanol. Samples were then critical point dried, sputter coated and viewed in a Hitachi
Temscan electron microscope.
2.14 Adherence of C. ieiuni to eukaryotic host cells:
For a consistent population of organisms in all experiments £. ieiuni strain WD
2483 were harvested from BCYE agar plates and inoculated into thioglycolate broth to give

35

approximately 10s organisms/ml and incubated microaerobically at 37'C until the culture
concentration had reached 4-5 x 108 cfu/ml as determined by viable counts. Bacteria were
harvested by centrifugation at 3000 x g, washed in HBSS and resuspended in HBSS prior
to adherence assays. Six well plates with a confluent monolayer of either PCEF or Int 407
cells (2-3 x 106 cells/well) were inoculated with the bacterial suspension at a multiplicity of
infection (MOI) of 100 bacteria to 1 eukaryotic cell and incubated for up to 36 h. The
number of organisms bound to each cell type was assayed by viable counts and
immunofluorescence. At each time interval (1,2,4,6,12,24, 36 h) the monolayers were
washed with HBSS and the washing plated on the BCYE agar to assay the number of
unbound bacteria. Cells of the washed cell monolayers were lysed by adding 1.0 ml of
sterile Milli-Q water and 0.1 ml of this lysate was serially diluted and plated on the agar
plates. This gave the number of adhered as well as internalized organisms. To assay for
internalized bacteria only, at each time interval the infected monolayers were treated with
250 pg/ml gentamicin for three hours to kill the extracellular organisms. Monolayers were
washed thoroughly to remove gentamicin and cells were lysed by adding 1.0 ml of sterile
Milli-Q water. To assay solely for adherence, 1 pg/ml of cytochlasin B was added along
with the bacterial inoculum, to prevent phagocytosis and the washed monolayers were
lysed, serially diluted and plated as above.
Nonspecific binding of organisms to plastic culture plates were determined for each
experimental trial. For every well viable count estimations of unbound organisms
contained in washes made following the various incubation periods for adherence assays
were determined. This value was added to the corresponding lysate value for the
appropriate well and subtracted from the inoculum to give bacteria bound to the plastic.
Int 407 cells inoculated with £ . ieiuni strain WD 2483 at an MOI of 100:1 were
harvested at 2 ,6,12 and 24 h post infection and also examined for adhering or internalized
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organisms by electron microscopy. Infected and control cell monolayers were rinsed in 0.1
M cacodylate buffer, fixed in 5% glutaraldehyde, post fixed in 1% OSO4, dehydrated in a
graded ethanol series and prepared for SEM and TEM as described in section 2.8

Ihfi.Xmdn
2.15 Localization of the toxin in the organism:
The £ . jejuni toxin isolated in this study is secreted by the organism and the
treatment of the bacterial cells with polymyxin B does not increase the toxin concentration
in the broth suggesting that the toxin is not localized in the periplasm. The localization of
this toxin in the organism prior to its secretion was studied by the various techniques
described below.
a)

Cellular fractionation of strain WD 2483: The method described by

Schnaitman (128) was used to separate outer membrane proteins, cytoplasmic membrane
proteins, and soluble (cytoplasm and periplasm) proteins as outlined in Fig 4. £. ieiuni
cells were suspended in HEPES buffer (pH 7.0) with 1 mM phenyl-methyl-sulfonylfluoride (PMSF) and broken mechanically using glass beads in a Sorval Omni Mixer. The
intact cells were removed by sedimentation at 5000 x g for 5 min. Broken cells were
centrifuged at 200,000 x g for 60 min in a Beckman L8-70 ultracentrifuge (Beckman
Instruments, Inc., Palo Alto, CA). Sediment 1 was removed and the supernatant
incubated at 21*C for 30 min to allow tiny membrane lipid fragments to aggregate. Failure
to include this incubation step would prevent these small fragments from sedimenting in
ultracentrifuge. After incubation, supernatant 1 was centrifuged at 200,000 g for 60 min.
Supernatant 2 was collected which contained the cytoplasmic and periplasmic proteins.
The sediment 2 was combined with sediment 1 and suspended in HEPES buffer at 10 mg
of protein per ml. Triton X-100 was then added at a final concentration of 20 mg/ml
protein. This was centrifuged at 30,000 x g for 60 min and the sediment and supernatant
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LYSED£. JEJUNI CELLS
centrifuged at 200,000 x g
for 60 min

SUPERNATANT 1

SEDIMENT 1

incubated at 21° C
for 30 min and centrifuged
at 200,000 x g for 60 min
SUPERNATANT 2
(cytoplasm and periplasm)

SEDIMENT 2 + SEDIMENT 1
centrifuged at 200,000 x g
for 60 min

SUPERNATANT 3
(cytoplasmic membrane)

SEDIMENT 3
(outer membrane)

Figure 4: Scheme followed to separate the different cellular components of lysed
Campvlohacter ieiuni cells. The cells were lysed using glass beads and the intact cells were
removed by centrifuging at 5000 x g for 5 min.
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were both collected. The supernatant 3 contained the cytoplasmic membrane fractions
while the sediment 3 contained the outer membrane fraction of the organism.
The relative activity of succinic dehydrogenase (SDH), an integral enzyme of the
cytoplasmic membrane (30), and the concentration of 2-keto-3-deoxyoctonate (KDO), a
constituent of outer membrane lipopolysaccharide, were used as indices of the purity of cell
fractions (62).
b)

SDS-PAGE analysis and Immunoblotting: The protein concentrations of

the cell fractions obtained from the above described techniques were determined by the
method of Lowry (87) and 8 jig of protein of each of the cellular components was loaded in
separate wells of the polyacrylamide gel and separated by SDS-PAGE. All cell fractions
were loaded in duplicate. After electrophoresis, the gel was cut in half. One-half was
silver stained to reveal the proteins while the other half was transferred onto a nitrocellulose
membrane following the Western blot technique (152). Transferred nitrocellulose blots
were incubated in the MAb (CETPMAb^ to the £. ieiuni ETP, washed in TBS,
reincubated in goat anti-mouse-horseradish peroxidase and the immunoblots were
developed in 4-chloro-l-naphthol as described in section 2.3.
c)

ELISA: ELISA experiments were performed with 96 well plates coated with the

separated cell fractions of strain WD 2483. Equal concentrations of protein (50 pg/well)
were added to the 96 well plates and left overnight at room temperature. Excess protein
was removed by washing with T-PBS, after which the plates were post-coated with 0.3 ml
of 3% bovine serum albumin for 30 min. All plates were washed with T-PBS and 100 pi
of CETPMAb4 was added to each well for 2 h followed by incubation in 100 pi of goat antimouse-horseradish peroxidase conjugate (section 2.4). Similarly coated plates were also
incubated with polyclonal antiserum to the whole organism and subsequently incubated in
goat anti-rabbit-horseradish peroxidase conjugate to serve as positive control. The color
intensity was read using an EIA reader at 405 nm.
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d)

Imrnuno electron microscopy: Thawed samples of strain WD 2483 were

grown on BCYE agar plates micioaerobically at 37*C and the organisms were harvested in
5 ml of PBS. They were washed twice and centrifuged at 3000 x g for 5 min. The
resultant pellet was lightly fixed in 0.5% glutaraldehyde for 10 min, suspended in 10%
DMSO for 30 min and immediately freeze-thawed at -70*C. The thawed sample was
thoroughly washed in PBS to remove all traces of DMSO and was then incubated in a 1:10
dilution of CETPMAb4 for 2 h at 37C with continuous shaking. After two washings in
PBS to remove unbound globulin, the samples were incubated in a 1:10 dilution of goldconjugated goat anti-mouse serum (Organon Teknika Corp.) at room temperature.
Unbound globulin was removed by washing and the samples were fixed in 5%
glutaraldehyde and embedded for electron microscopy (section 2.6).
2.16 N ature of the toxin:
The nature of the toxin isolated from strain WD 2483 was determined b y : a) the
CHO cell assay; b) GMi ganglioside binding assay and c) the cytopathic effects induced in
the PCEF and Int 407 cells.
a)

CHO cell assay: As described by Guerrant et al. (47), the CHO cell assay was

performed with the ETP to establish the nature of the toxin. Cell monolayers were grown
on 6 well plates with glass coverslips (section 2.2). The percentage of elongated cells were
calculated after incubating the cells with the ETP (0.01,0.1 and 30 (ig/ml) for 24 h at
37*C. Assays were repeated using the bacterial cell-free filtrates of the remaining 6 strains
of £• jejuni at a protein concentration of 30 |ig/ml. Heat labile enterotoxins were obtained
in similar fashion from £• £qU strain H I0407 (Dr. Stanley Falkow, Stanford Univ., CA)
and Vibrio cholerae strain 2868 (Dr. Rita Colwell, Univ. of Maryland, MD) grown
overnight in tryptic soy broth to a density of approximately 5 x 107 cfu/ml. The broth was
filtered through a 0.2 pm filter and the cell-free filtrate was added to CHO cell monolayers
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at protein concentrations of 0.01,0.1 and 30 pg/ml as positive controls
b)

Binding to OMi gang)inside: It is a characteristic feature that E. coli and V.

cholerac enterotoxins bind to the monosialoganglioside (GMi) and the use of GMi as a
specific sorbent for enterotoxins has been an alternative approach for their identification (4,
126). Therefore, similar ELISA experiments were performed in which wells of the
microtiter plates were each coated with 100 pi of a 1.5 pM solution of GMi (Sigma) and
the binding of ETP and the 6 cell-free filtrates to the ganglioside were assayed,

y. cholerae

enterotoxin was used as a positive control in these binding studies. The antitoxin to y .
cholerae was kindly provided by Dr. James Kaper (Center for Vaccine Development,
Univ. of Maryland, Baltimore, MD).
c)

Cell culture assays: Int 407 cells and PCEF cells were used to determine the

cytotoxic activity of the ETP. Cells were grown in 6 well plates as confluent monolayers,
incubated with ETP (100 ng/ml protein) or the remaining six bacterial cell-free filtrates (30
jig/ml) and observed for 36 h for any cytotoxic or cytolytic effects. For neutralization of
the toxic activity, the ETP and the six filtrates were incubated at 37'C for 30 min with a
1:10 dilution of CETPMAb4. These were added to the Int 407 or PCEF cells in 6 well
plates and examined for cell changes.
2.17 Toxin binding studies:
Most toxins are known to adhere with specific receptors on the host cell surface
prior to the initiation of their toxic response. Hence, the binding of the ETP from £. ieiuni
strain WD 2483 was assessed using two cell cultures, PCEF and Int 407 cells,
a)

Maximal binding assav: ELISA was used to determine the binding of ETP to

the Int 407 and PCEF cells. To determine the time for maximum binding, the cell
monolayers were grown in 96 well plates (10s cells/well) and incubated with ETP (10 ng
protein) for various time intervals up to 36 h. The cell monolayers were washed three
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times with T-PBS and for each time interval 0.1 ml of CETPMAb4 and subsequently 0.1
ml of goat-anti mouse-horseradish peroxidase conjugate was added. The color intensity
was read using an EIA reader at 405 nm. To determine the amount of ETP required to
saturate the receptors on the host eukaryotic cells, similar monolayers in 96 well plates
were incubated with different concentrations of the ETP for 2 h and the binding measured
by ELISA as described above.
b)

Characterization of binding bv blocking experiments: The role of

eukaryotic surface proteins, glycoproteins, lipid and sugar moieties in the toxin binding
process was examined. The type, treatment, concentration and mode of action of the
agents used to modify the surface of the eukaryotic host cells are shown in Table S. With
the exception of glutaraldehyde (Electron Microscopy Sciences, Fort Washington, PA) all
agents were obtained from Sigma. Cells were treated with the agents for the time indicated,
washed three times with HBSS and the binding of ETP assayed by ELISA after the various
treatments.
Competitive blocking studies were conducted in the presence of mono- and
disaccharide sugars commonly found on mammalian mucosal surfaces, lectins and GMi
ganglioside. The type, treatment time and concentration of these agents are shown in Table
6. The agents were prepared at the specified concentration in HBSS and added to the cells
10 min prior to the addition of the ETP. After the binding period, the wells were washed
three times with HBSS and adherence was assayed by ELISA. HBSS was used in place of
the agents as control.
2.18

Interaction of the toxin with host cells:

a)

Electron microscopy of toxin treated Int 407 cells: Cell monolayers of

Int 407 cells were grown in 6 well plates and treated with the ETP for 2 ,6, and 12 h. After
the end of each time period, the monolayers were lightly fixed with 0.05% glutaraldehyde
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TABLE 5

ENZYMES AND OTHER AGENTS USED IN THE
EUKARYOTIC CELL TREATMENT PRIOR TO TOXIN
BINDING

Agents

Concentration

lim e
(min)

Function

Sodium metaperiodate

5mM

10

oxidation of CHO moieties

Nonidet P40

0.005%

60

action on membrane lipids

Glutaraldehyde

0 . 1%

10

immobilization of protein
moieties on membrane

Trypsin (type XI)

50 units/ml

30

Protease (type XIV)

0.005 units/ml

30

Chymotrypsin (type II)

0.1 units/ml

30

lipid, galactose or

Pepsin

100 units/ml

30

neuraminic acid-like

Neuraminidase (type VI)

1.0 units/ml

30

receptors on

Lipase (type I)

100 units/ml

30

eukaryotic cells

fi-galactosidase

100 units/ml

30
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degradation of proteolytic,

TABLE 6

AGENTS USED IN THE COMPETITIVE BINDING OF THE
TOXIN TO EUKARYOTIC CELLS

Agents

Concentration

Tune
(hour)

Wheat germ agglutinin

lOOpg/ml

2

Concanavalin A

lOOpgftnl

2

GMi ganglioside

lOOpg/ml

2

N-acetyl glucosamine

100 mM

2

N-acetyl galactosamine

100 mM

2

N-acetyl neuraminic acid

100 mM

2

a-D (+) - Fucose

100 mM

2

D (+) - Mannose

100 mM

2

B - D (+) Glucose

100 mM

2

D (+) Galactose

100 mM

2

D (-) - Ara binose

100 mM

2

B - D (-) Fructose

100 mM

2

Maltose4

100 mM

2

Sucroseb

100 mM

2

»: 4 - O - a - D - Glucopyranosyl - D- Glucose
b : a - D - Glucopyranosyl B - D - Fructofuranoside
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for 10 min. Similarly 12 h treated monolayers were incubated in 10% DMSO for 30 min
and then freeze-thawed at -70'C. Thawed monolayers were washed in cacodylate buffer to
remove DMSO, scraped from the plastic surface by means of a rubber policeman and
transferred to separate Eppendorf tubes. They were gently centrifuged at 200 x g for S min
and the pellets were incubated in 1:10 dilution of CETPMAb4 for 2 h at 37*C with
continuous shaking. After two washings in cacodylate buffer to remove unbound globulin,
the samples were incubated in 1:10 dilution of gold-conjugated goat anti-mouse serum
(Organon Teknika Corp.) at room temperature. Unbound globulins were washed and the
samples fixed in 5% glutaraldehyde and embedded for electron microscopy (section 2.8).
Similar cell monolayers of Int 407 cells grown in 6 well plates with cover slips
were treated with the ETP for 2 ,6, and 12 h and prepared for SEM as described in section
2.8 to look for toxin induced surface changes on the eukaryotic host cells,
b)

Fractionation of Int 407 cells: The method described by Krueger et al. (74)

was used to separate the lysed Int 407 cells into different fractions. Cell monolayers of Int
407 cells were treated with ETP for 12 h and the cells were scraped off the flasks with a
rubber policeman. They were suspended in PBS and pelleted by low speed centrifugation.
The cell pellets were resuspended in 10 ml of buffer containing 10 mM KC1,20 mM tris
(pH 7.0), 0.1% 2-mercaptoethanol, 1 mM EDTA and 250 pg/ml PMSF (Sigma) and
allowed to swell on ice for 10-20 min. Swollen cells were homogenized by 50 strokes
with a tight-fitting Dounce homogenizer. As judged by phase contrast microscopy, all cells
were lysed but the nuclei were still intact
Cellular fractionation was performed by a series of centrifugation steps (Fig 5).
The cell lysates were centrifuged at 1000 x g for 5 min and obtained a pellet enriched in the
nuclei. The resultant post nuclear supernatant was centrifuged at 12,000 x g for 10 min
and a pellet of the cellular membranes was obtained. Further centrifugation of the
supernatant at 200,000 x g for 45 min yielded as a pellet the small granular fraction while
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HUMAN INTESTINAL 407 CELLS
treated with ETP
for 12 h
LYSED IN A DOUNCE HOMOGENIZER
centrifuged at 1000 x g
for 5 min

p o s t -n u c l e a r f r a c t io n

pellet

(nuclei fraction)
centrifuged at 12,000 x g
for 15 min

PELLET
(membrane fraction)

SUPERNATANT
centrifuged at 200,000 x g
for 45 min

PELLET
SUPERNATANT
(small granular fraction)
(soluble cytoplasmic fraction)
Figure 5: Scheme followed to separate the different cellular components of the eukaryotic
human intestinal 407 (Int 407) cells.
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the supernatant contained the soluble cytoplasmic protein fraction. The relative activity of
SDH, an integral enzyme of the plasma membrane was used to establish the purity of the
cell fractions (30).
c)

SDS-PAGE analysis and Immiinoblotting: The protein concentration of the

cell fractions was determined by the method of Lowry (87) and 8 pg of protein of each of
the cellular components was loaded in different wells and separated by SDS-PAGE. The
cell fractions were loaded in duplicate on the same gel. After electrophoresis, the gel was
cut in half and one-half silver stained to reveal proteins while the other half was transferred
onto a nitrocellulose membrane by Western blot technique (152). Transferred
nitrocellulose blots were incubated in the MAb (CETPMAb4) to the £ . ieiuni ETP, washed
in TBS, reincubated in goat anti-mouse-horseradish peroxidase and the immunoblots were
developed in 4-chloro-l-naphthol as described in section 2.3.
d)

ELISA: ELISA experiment were performed with 96 well plates coated with the

separated cell fractions of Int 407 cells treated with ETP for 12 h. Equal concentration of
proteins (50 pg/weU) was added to the 96 well plates and these were incubated overnight.
Excess protein was removed by washing each well in T-PBS, after which 100 pi of a 1:10
dilution of CETPMAb4 was added for 2 h and this was followed by incubadon in 100 pi of
goat anti-mouse-horseradish peroxidase conjugate for 1 h. After washings with T-PBS,
TMB substrate was added to each well and the reaction stopped with 2 M sulfuric acid.
The color intensity was read using EIA reader at 405 nm.
e)

Indirect Immunofluorescence assav: Int 407 cells were grown as confluent

monolayers in 6 well plates with glass coverslips. They were treated with ETP (100
ng/well) for 12 h and subsequently fixed with either 1 ml of 0.5% glutaraldehyde in
cacodylate buffer or methanol. Fixed monolayers were washed and treated with polyclonal
antiserum to strain WD 2483 or the monoclonal antibody, CETPMAb4 followed by goat
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anti-rabbit or goat anti-mouse FITC and viewed using an Olympus epifluorescent
microscope. Similar fixed monolayers were treated in duplicate with 0.2 mg/ml of trypsin
for 10 min to remove any bound toxin, one set of monolayers was lysed while the other set
of cells was left intact and prepared for fluorescence microscopy (section 2.7).
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RESULTS
3.1 Identification an d biotvpinq o f the strains
All seven clinical strains were confirmed as Campylobacter ieiuni based on the
morphological and biochemical tests outlined in Table 7. These strains were Gramnegative with a spiral S- shaped morphology and were motile with a characteristic darting
corkscrew-like motion. They were oxidase and Cata la n positive and hydrolysed hippurate.
According to the biotyping scheme of Lior (85) shown in Table 2 all the strains belonged to
biotype 1 as none produced H2S or DNase.
3.2 Histopatholoeical observations in the chick embrvo
The LD50 values for Q. ieiuni strain WD 2483 introduced into the chick embryo by
different routes of inoculation were determined and are shown in Table 8. The number of
organisms required to induce lethality in eggs ranged from 2.1 x 102 cfu/ml for organisms
inoculated into the amniotic cavity to 9.5 x 104 cfu/ml for allantoic sac. The LD50 results
demonstrated that inoculation of relatively small doses o f organisms into the immediate
environment or into the nutritional source of the embryo were sufficient to kill embryos as
compared to the dose required for more peripheral routes.
Examination of embryo organs such as liver, heart, kidney, spleen and the GI tract
after yolk sac inoculation with multiple doses of the yolk sac LD50 are summarized in Table
9 and illustrated in Plates 1 to 5. The control tissue sections from 14 day old embryos are
shown in Plates la to 5a. The liver parenchyma was observed in a continuous lattice with
radially disposed central veins throughout the tissue (Plate la). The contractile myocardial
muscle fibers forming a network were easily discemable in the heart tissue (Plate 2a).
Section through the kidney showed the well spaced proximal and distal tubules and
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glomeruli with dispersed red blood cells (Plate 3a). The spleen tissue appeared organized
with the white pulp scattered throughout the red pulp (Plate 4a) and the GI tract showed the
columnar epithelial cells and the crypts of Liebeikuhn extending into the lamina propria
typical of their structure (Plate 5a). The embryo organs inoculated with 10,100 or 1000
times the yolk sac LD50 of £ . jejuni strain WD 2483 showed congestion of the blood
vessels, slight tissue damage due to edema, and small amounts of hemorrhage (Plates lb to
5b). Cell breakdown or necrosis were not evident. The lack of an inflammatory infiltrate
was striking and was observed in all organs examined irrespective of the inocula used or
the time post-inoculation. The heart was highly congested and the tissue was disrupted as a
result of edema (Plate 2b). In the kidney tissue the convoluted tubules were condensed and
the glomeruli were not clearly visible (Plate 3b). The congestion in spleen tissue was less
severe than in liver, heart or kidney (Plate 4b). Surprisingly, the GI tract looked similar in
appearance to the control tissues throughout the study (Plate 5b). The chorio-allantoic
membrane did not show any visible pocks or pathological changes. The histological
changes in different organs did not appear dll day 3 post-inoculation and were most severe
from day 5 to day 8 post-inoculation. The tissues from day 1 and day 2 post-inoculation
appeared normal.
Inoculation of multiple doses of yolk sac LD50 resulted in the growth and
multiplication of the organism only in the organ of inoculation, yolk sac. There was a 3 log
increase in the number of organisms by day 5. The bacterial colony counts of aseptically
removed homogenized embryo organs showed no bacteria irrespective of time post
inoculation. Indirect immunofluorescence studies on deparaffinized tissue sections and
formalin fixed homogenates also showed that dissemination of the organisms had not
occurred in any of the embryo organs.
Inoculation of the cell-free filtrate of the strains of £. jejuni intra-yolk sac in 6 day
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old eggs induced lethality. Filtrate from strain WD 2483 (originally containing 5 x 107
cfu/ml) was found to be most toxic as it retained toxicity fa- the eggs when diluted up to
1(H while strain WD 2914 (originally containing 6.8 x 107 cfu/ml) and BS 1 (originally
containing 8.0 x 107cfu/ml) retained toxicity only up to 10-2 (Table 10). Inoculation of
yolk sacs with bacteria-ftee filtered broth obtained from strain WD 2483 induced within
24 h histopathological changes similar to those produced by organisms (Plates lc to 5c).
The liver, heart, kidney and the spleen showed congestion, edema and hemorrhage while
the GI tract appeared as the controls.
Toxicity of these filtrates for embryos was destroyed by exposure to heat at 60'C or
100'C for 15 min, pH 3.0, pH 9.0, trypsin, or protease but not to lipase or long term
storage at 4‘C. There was no effect on the amount of toxin produced when the bacterial
cells were treated with 1 mg/ml of polymyxin B to release the periplasmic proteins.
3.3 Electrophoretic pattern of the concentrate from Cam pylobacter ieiuni
The preparative PAGE of the concentrated dialyzed cell-free filtrate from £. ieiuni
strain WD 2483 showed four bands after staining with Coomassie blue (Plate 6, lane A).
After each of these bands were separately electroeluted and injected into the yolk sac of
eggs, only one of the protein bands proved to be lethal to the embryos. Pieces of
aery1amide were electroeluted in a similar fashion and 0.1 ml injected into eggs as controls.
No mortality was observed. The SDS-PAGE of this eluted toxic protein (ETP) yielded two
bands, one at 68 kilodalton and the other at 65 kilodalton (Plate 6, lane B and C). When
similar unstained bands were eluted out of the reducing gel and injected into eggs, no
mortality was observed. The lethality of the ETP for the fertile hen's egg was abolished by
treatment with 0.5 mg/ml of trypsin and protease, freeze-thawing, heating at 60*C or
100'C, but not with lipase or storage at 4*C for up to 4 weeks (Table 11).
Monoclonal antibody: While screening the various monoclonal antibodies raised

51

against the toxin of Q. jejuni, forty clones were found to be specific for the ETP. ELISA
readings of greater than 0.15 at 405 nm were achieved when Int 407 cells previously
treated with the ETP for 2 h were probed with the supernatant of each. When 100 p.1 of the
globulin containing medium from these clones was incubated with the ETP for 30 min and
injected into the yolk sac of 6 day old eggs, one clone was found that destroyed the toxicity
of the ETP for the eggs. This clone was further tested for specificity by immunoblotting
using the standard Western blot technique described in Section 2.5. Immunoperoxidase
probes of ETP resolved by SDS-PAGE and transferred to nitrocellulose showed both the
65 and 68 kilodalton protein bands when the primary antibody used was the polyclonal
antiserum raised against £. jejuni strain WD 2483 (Plate 6, lane D). However, the
supernatant from the clone (CETPMAlxj) which abolished lethality for eggs reacted with
only the 68 kilodalton band (Plate 6, lane E).
3.4 Pathogenesis of Cam pylobacter ieiuni on host eukaryotic cells
PCEF and Int 407 cells inoculated with £ . iejuni strain WD 2483 at an MOI of
100:1 were observed for cytopathic and/or cytolytic affects. No significant visible changes
were seen until 6 h post-inoculation. However, by 12 h up to 50% of the cells were
rounded There was extensive cellular vacuolation resembling fatty degeneration and a
number of refractile cells were observed (Plates 7 and 8). By 24 h a majority of the cells
had lysed and were no longer attached to the bottom of the wells.
Bacterial binding to PCEF and Int 407 cells of C jejuni stain WD 2483 at a MOI of
100:1 was assayed for up to 36 h and the resultant adherence kinetics data are shown in Fig
6 and 7. At this inoculum level, marked non-specific binding of the organisms to the
plastic of the culture dishes was observed. Approximately, 3-4 x 106 cfu/well bound nonspecifically when the inoculum was 2 x 108 cfu/well. Viable count assay of the lysate of
cell monolayers treated with 250 Jig/ml gentamicin showed no internalized bacteria,
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irrespective of the time post-inoculation. The maximum adherence was at 4 h post
inoculation in both cell lines which corresponds to an average cfu/eukaryotic cell ratio of 1
per 10 cells. IFA equivalent ratios were 1 bacterium per 20 cells for Int 407 and 1
bacterium per 25 PCEF cells. The data indicated that 0.1% of the inocula bound to the cells
while 1.6 -2.0% of it bound to the plastic showing approximately a twenty times higher
efficiency of bacterial binding to the plastic than the host eukaryotic cells.
Ultrastructural observations of Int 407 cells inoculated with strain WD 2483 and
incubated for 2 ,6,12 and 24 h are shown in Table 12 and illustrated in Plates 9 to 13. The
control Int 407 cells had cell membranes rich in microvilli. Within the cytoplasm the golgi
apparatus could be clearly seen (Plate 9) and the mitochondria with complex membrane
configuration were typical in appearance. The Int 407 cells had large nuclei. Cell
monolayers inoculated with the organisms at an MOI of 100:1 and incubated for 2 h
appeared, in general, similar to the controls except for the presence of membrane enclosed
amorphous-staining bodies observed in all cells (Plate 10). By 6 h post-inoculation
mitochondrial damage along with initial stages of cytoplasmic clearing and membrane lysis
were obvious (Plate 11). At 12 h post-inoculation there was breakdown of cytoplasmic
and nuclear membranes as well as clearing of the cytoplasm of affected cells. Apparently
empty mitochondria were seen. Cells showed margination of the chromatin material with
nuclear clearing and this along with dilation of the perinuclear region and ballooning of the
nuclear membranes was the most common feature (Plate 12). By 24 h post-inoculation
most cells were lysed and in the few surviving cells ghost mitochondria, cytoplasmic
clearing with chromatin margination and ballooning of the nuclear membrane were
observed consistently (Plate 13). At no time through out the study were internalized or
adherent bacteria observed.
Scanning electron microscopy of these infected cell monolayers at 2 ,6,12 and 24 h
post-inoculation confirmed the cellular damage observed by TEM and this is illustrated in
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Plates 14 and 15. The degree of cell damage increased with time. The untreated control
cells appeared as relatively uniform monolayers with occasional clumped cells showing
those cells undergoing mitosis (Plate 14). The Int 407 cells treated with £. jejuni strain
WD 2483 for 2 h appeared similar to the control (Plate 15a). Cell damage was evident at 6
h post-inoculation by which time the monolayer had lost its integrity and many rounded
clumps of cells were seen (Plate 15b). Numerous blebs were observed on the surface of
infected cells and cell lysis was apparent The damage to the cells increased progressively
through 12 and 24 h post-inoculation (Plate 15 c and d). At no time throughout the study
were any bacteria observed adhering to or penetrating the host eukaryotic cells.
3.5 Localization of the toxin in the organism
Electrophoretic profile of the three cellular fractions; outer membrane, cytoplasmic
membrane as well as cytoplasm and periplasm of strain WD 2483 and their Western blot
subsequently derived from these are shown in Plate 16. The molecular weight markers are
located in lane a. The banding patterns of the proteins from the outer membrane,
cytoplasmic membrane and soluble protein (cytoplasm and periplasm) fractions respectively
are shown in lanes b, c and d. Approximately 10 protein bands could be seen in the outer
membrane profile of the organism and these bands ranged in molecular weight from 18 to
68 kilodaltons. The OMP profile was dominated by 3 protein bands at 25.7,43 and 68
kilodaltons. The 43-kilodalton protein is thought to be a porin. Lane e, f, g and h are the
immunoblots of the soluble proteins, cytoplasmic membrane, outer membrane and the
molecular weight markers probed with CETPMAbu. The monoclonal antibody showed
antigenic specificity for five bands in the outer membrane fraction and these corresponded
to bands with approximate molecular weights of 20,23,35,43 and 68 kilodaltons. No
protein bands in the cytoplasmic membrane or the cytoplasmic and periplasmic fraction
were recognized by the monoclonal antibody. The percent purity of the cell fractions
analyzed by succinate dehydrogenase (SDH) activity showed 82% of the SDH activity in
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the cytoplasmic membrane fraction with 10% in the cytoplasmic & periplasmic fraction and
8% in the outer membrane fraction. With respects to the concentration of 2-keto-3deoxyoctonate (KDO), approximately 80% occurred in the outer membrane with 13% in
the membrane fraction and 7% in the cytoplasmic and periplasmic fraction of strain WD
2483.
These cellular fractions were coated onto 96 well plates overnight and ELISA was
performed using CETPMAb4 and goat anti-mouse horseradish peroxidase. The
absorbance at 405 nm of the different fractions is shown in Fig 8. The monoclonal
antibody bound to proteins in the outer membrane fraction with an absorbance value 0.194
as compared to almost negligible absorbance values for the cytoplasmic membrane or
cytoplasmic and periplasmic fractions. However, the cellular fractions probed with the
polyclonal antibody to strain 2483 showed specificity for all three fractions.
£. jejuni organisms probed with the monoclonal antibody, CETPMAb4 and gold
conjugated antiserum are illustrated in Plate 17. The gold probe was seen attached only to
the outer membrane in small amounts. On average only one or two sites on the outer
membrane with gold particles occurring singly or in clumps were observed per cell.
Control organisms that were treated with PBS instead of CETPMAtu and the conjugated
antiserum showed no probe (Plate 17a). In freeze-thawed samples the organisms were
seen almost deprived of cytoplasm and most were lysed. In these lysed and deformed
bacterial cells the probe was seen attached to the outer membrane (Plate 17b). At no
instance was the gold probe seen inside the organisms. Normal washed £. jejuni
organisms probed with the monoclonal antibody and the conjugated antiserum again
showed the gold particles attached to the outer membrane only (Plate 17c).
3.6 Nature of the toxin
The effect of the ETP, cholera and E- coli enterotoxins on CHO cells are illustrated
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in Plate 18. The ETP caused rounding of about 70-80% of the CHO cells at 24 h post
inoculation (Plate 18b) and of these rounded cells 72% were non-viable by trypan blue
assay. The enterotoxins of X- cholerae and £. coli showed elongation in approximately
75% of the CHO cells by 24 h (Plate 18c and 18d). When the ETP was incubated with
CETPMAtu for 30 min and added to the CHO cells, no cytotoxic activity was observed.
However, the monoclonal antibody did not neutralize the cholera or £. coli enterotoxin and
cholera antitoxin had no effect on the ETP as determined by cell culture and fertile hen's
egg lethality assay. The cell-free filtrate of the remaining 6 strains of £. ieiuni showed
rounding of 68-82% of the CHO cells and their cytotoxic activity was neutralized when 0.1
ml of the filtrate was incubated with 1:10 dilution of the monoclonal antibody for 30 min.
None of these crude filtrates shared any immunologic resemblance with the cholera toxin in
that the antisera against cholera toxin did not neutralize their toxic activity (Table 13).
Binding of the various toxins to GMi ganglioside as measured by ELISA are
illustrated in Fig 9. The cholera and £, coli enterotoxins avidly bound the ganglioside
while the ETP or the crude toxic filtrates from the other 6 £. jejuni strains showed no
binding. The results illustrated are an average of three separate trials.
The effect of the ETP on PCEF and Int 407 cells were observed by inverted
microscopy and are illustrated in Plates 19 and 20. No significandy visible changes were
seen prior to 2 h post-inoculation but some granular cells were observed after 6 h.
However by 12 h approximately 80% of the cells in both the cell lines had rounded up. Of
these rounded cells 78% were non-viable in trypan blue exclusion assays and all the
detached cells floating in the medium were dead. There was cellular vacuolation
resembling fatty degeneration observed in the affected cells. A number of reffacdle cells
were also seen. The cytopathic effects induced on the cell lines were similar to those
induced by the organism. By 24 h most of the cells had lysed and were no longer attached
to the wells.
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3.7 Binding specificity of the toxin
The binding curves of ETP to PCEF and Int 407 cells are summarized in Fig 10 and
11. As observed, the ETP bound avidly to both the cell lines and this was maximal after 2
h incubation at 37*C. The maximum binding values of the toxin obtained by ELISA were
0.378 for the PCEF cells and 0.412 for the Int 407 cells. The adherence subsequently
decreased and by 24 h most of the cells were rounded or lysed. The saturation curves for
the toxin receptors on both PCEF and Int 407 cells are shown in Fig 12 and 13. In both
cell cultures, 10 ng of ETP saturated all the receptors on eukaryotic host cell monolayers in
96 well microtiter plates and there was no significant difference observed in toxin binding
on increasing the protein concentration to as high as 10 pg/well.
The binding of toxin to host cell membranes is a complex process and experimental
procedures could lead to contradictory results. For these reasons treatments that reduced
binding by 50% or more as compared to the untreated controls are considered significant.
In this study similar inhibition levels were used to measure the significance of the various
treatments for the binding of ETP to PCEF or Int 407 cells. Fig 14 and 15 illustrates the
percent reduction in toxin binding following modification of the host eukaryotic cell
surfaces with the agents listed in Table 5. Proteolytic enzymes, neuraminidase and
glutaraldehyde reduced adherence of the ETP by more than 50% in both cell lines while
treatment with B-galactosidase, lipase, sodium metaperiodate and Nonidet P-40 had no
significant affect
Coincubation of PCEF and Int 407 cells with sugars, lectins and GMi ganglioside
listed in Table 6 are shown in Fig 16 and 17. Of the lectins, GMi ganglioside or the sugars
tested only N-acetyl neuraminic acid (NurNAc) significantly reduced toxin binding.
NurNAc reduced adherence by 50% and 56.5% in Int 407 and PCEF cells respectively.
The remaining mono- and disaccharide sugars each accounted for less than 7% reduction in
toxin binding.
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3.8 Fate of the toxin after interaction with Int 407 cells
Ultrastructural observations on Int 407 cells treated with ETP for 2,6 and 12 h and
probed with monoclonal antibody and gold-conjugated goat anti-mouse serum are
summarized in Table 14 and illustrated in Plates 21 to 23. The effect of the toxin was
clearly visible at 2 h and the mitochondria showed the most damage (Plate 22). Initial
stages of cytoplasmic clearing accompanied by some fatty degeneration was observed.
Breakdown of cell membranes with ballooning of the nuclear membrane by 6 h was very
striking and consistent throughout the study (Plate 23). The mitochondria were severely
damaged with degeneration of these organelles and at later stages apparently empty
mitochondria were seen. The microvilli were fewer and blunted as compared to the normal
cells. By 12 h there was breakdown of cytoplasmic and nuclear membranes and clearing of
the cytoplasm in cells. Dilation of the perinuclear space with ballooning of the nuclear
membrane was seen (Plate 24). A majority of the cells had lysed and a few surviving cells
showed margination of the chromatin material with nuclear clearing. At this stage, the
microvilli had almost disappeared (Plate 25).
SEM analysis of the Int 407 cells treated with ETP confirmed the cell damage
observed by TEM and is illustrated in Plates 26 and 27. Compared to the untreated control
Int 407 cells (Plate 26), the cell damage induced by the toxin in 2 h was marked (Plate
27a). The monolayers were stretched and appeared to be split apart. By 6 h the effect of
the toxin was quite pronounced with cells showing numerous blebs on the surface and the
integrity of the monolayers was lost (Plate 27b). At 12 h post-treatment 80% of the cells
had rounded up with lysed surfaces as shown in Plate 27c and 27d.
The gold probe was seen at all times and was only attached to the cell membranes.
At no instance was the probe seen in the cytoplasm. Interestingly, it seemed that the probe
was found attached mostly to the microvilli in cells treated with the ETP for 2 and 6 h. In
freeze-thawed toxin treated cells, no probe was seen at any time (Plate 25). However, the
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toxic effects of the ETP were clear in the freeze-thawed cells.
Electrophoretograms of each soluble fraction of Int 407 cells treated with the ETP
for 12 h are shown in Plate 28. Lanes a, b, c and d contain the soluble cytoplasmic
fraction, membrane fraction, nuclei fraction and the small granule fraction respectively.
Lane e has the molecular weight markers. In each of these fractions, more than 60 proteins
are evident including several major proteins with molecular weights ranging from 20 to 90
kilodaltons. The percent purity of the cell fractions analyzed by succinate dehydrogenase
(SDH) activity showed most of the enzymatic activity in the membrane fraction (79%) with
7% in the small granule fraction, 2% in the soluble cytoplasmic fraction and 12% in the
nuclei fraction. Immunoblots of these cellular fractions and the molecular weight markers
probed with the monoclonal antibody, CETPMAh4 are shown in Plate 28, lanes f to j in the
same order as above. The monoclonal antibody showed antigenic specificity for four
bands in the membrane fraction at approximate molecular mass of 32,43,54 and 63
kilodaltons. No other protein bands in any of the remaining three fractions were positive
on probing with the monoclonal antibody.
These cellular fractions were coated onto 96 well plates overnight and ELISA was
performed using CETPMAb4 and goat anti-mouse horseradish peroxidase. The
absorbance values at 405 nm of the different fractions are shown in Fig 18. The
monoclonal antibody bound to proteins in the membrane fraction with an absorbance value
of 0.163 as compared to almost negligible absorbance values for the other three fractions of
the Int 407 cells.
Immunofluorescence results of Int 407 cells incubated with the ETP for 12 h after
various treatments probed with either the polyclonal antibody or the monoclonal antibody,
CETPMAh4 are summarized in Table 15 and illustrated in Plates 29 to 31. Positively
fluorescing cells were observed after fixation with either glutaraldehyde or methanol (Plates

59

29a and 30a). No fluorescence was seen in cells which were trypsin treated to remove cellmembrane bound toxin (Plates 29b and 30b). Similar fluorescence was observed in lysed
cells which were not trypsin treated (Plate 31a) but cells that were trypsin treated and
subsequently lysed showed no binding of the FTTC-conjugated antiserum (Plate 31b).
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TABLE 7

MORPHOLOGICAL AND BIOCHEMICAL
CHARACTERISTICS O F THE STRAINS
- non spore forming
- Gram negative spiral S- shaped
- microaerophilic
- darting cork screw like motility
- oxidase (+)
- catalase (+)
• nitrate reductase (+)
- H2S production on TSI (-)
- oxidation of carbohydrates (-)
- hippurate hydrolysis (+)
- growth at 25*C (-)
- growth at 42*C (+)
- biotype 1
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TABLE 8

LDso ENDPOINTS OF £ . JE JU N I STRAIN WD 2483 FOR
THE FOUR ROUTES OF INOCULATION IN THE FERTILE
HENS' EGGS

Routes

Colony fonning units/ml*
Average
Ranged
9.5 x 104

8.8 x 1 0 4 .9.9 x 104

Amniotic sac

2.1 x 102

1.9 x 102-3.8 x 102

Yolk sac

3.3 x 102

2.0 x 102. 5.6 x 102

Yolk sac (washed)

1.0 x 1(P

8.8 x 102-3.1 x 103

Chorioallantoic membrane

8.0 x 103

6.5 x 103 .9 .5 x 103

Allantoic cavity

a : data represents an average of three separate experiments
b : the lowest and highest LD50 of the three experiments for each inoculum site.
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TABLE 9

HISTOPATHOLOGICAL OBSERVATIONS IN EMBRYO
ORGANS INOCULATED WITH 10, 100 OR 1000 TIMES
THE YOLK SAC LDS0 O F £ . JE JU N I STRAIN WD 2483«

Changes in embryo
tissuesb

Days post-inoculation
12
34
5678

congestion of blood vessels

-

++

+++

edema

-

+

++

hemorrhage

-

+

++

inflammatory response

-

necrosis

.

.

.

•: inoculation intra-yolk sac at 6 days of development
b : liver, heart, kidney and spleen showed identical results. Gastrointestinal tract
appeared similar to controls throughout the study period
- = damage not found; + = slight; ++ = moderate; +++ = severe
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TABLE 10

ACTIVITY OF THE CELL FREE FILTRATES FROM
C . .IE.IUNI

Strain

cfu/ml*

Dilution**

WD 2483c

5.0 x 107

10-4

WD2914

6.8 x 107

10-2

WD2920

1.0 x 10«

10-3

WD2939

1.2 x 10»

10-3

M AI

1.5 x 108

10-3

MA2

4.0 x 108

10-3

BS 1

8.0 x 107

10-2

»: Strains were grown in thioglycolate broth microaerobically at 37°C for 48 h, assayed
for viable counts as cfu/ml and prepared as bacterial cell-free filtrates
b : Highest dilution of C. ieiuni cell-free filtrate inducing death in eees. Dilutions of
frltrate tested were from lO 1 to 10*7
c : strain used in subsequent characterization studies
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TABLE 11

PHYSICO-CHEMICAL CHARACTERIZATION OF THE
ETP ISOLATED FROM £ . JE JU N I STRAIN WD 2483

Treatment

Time

0.5 mg/ml trypsin

30 min

0.5 mg/ml protease

30 min

0.5 mg/ml lipase

30 min

pH 3.0

30 min

pH 9.0

30 min

60*C

15 min

100*C

15 min

freeze-thaw

10 min

storage at 4*C

4 weeks

Lethality in fertile hens' eggs

+

+

+ = Induced death in eggs
- = No mortality
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TABLE 12 ULTRASTRUCTURE CHANGES IN INT 407 CELLS AFTER
INOCULATION W ITH £ . JE JU N I STRAIN WD 2483 AT AN
M O I OF 100:1
Cell damage or feature
2

Hours post-inoculation
6
12
24

break down of cell and nuclear membranes

-

+

+++

+++

cytoplasmic clearing

-

-

+++

+++

fatty degeneration

-

-

+++

+++

ballooning of nuclear membrane

-

-

+++

+++

mitochondrial damage

-

+

+++

+++

margination of chromatin

-

-

+++

+++

membrane bound amorphous inclusions

++

++

++

++

Presence of Q. iejuni organisms
adherent to cell membranes

-

intracellular

.

.

.

.

- = Cell damage or feature not found; + = Slight; ++ = Moderate; +++ = Extensive
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TABLE 13

CYTOLOGICAL CHANGES IN CHO CELLS DUE TO THE
TOXINS OF £ . JE JU N I. Y- CHO LERAE OR £ . Q Q L 1 AFTER
INCUBATION W ITH ANTISERA

Toxin

Percent effect on cells after incubation with11
no antiserum
CETPMAb4
Cholera antitoxin

£• jejuni
ETP (0.1 pg/ml)

80

4

75

ETP (0.01 |ig/ml)

70

2

68

Filtrates finom 6 additional
<10

68-82

75

72

9

Y- cholerae (Q-i jig/mi)

62

68

0

V. cholerae (0.01 uc/mll

10

8

0

E. £Qli (30 jig/ml)

75

72

15

E. coli (0.1 Hg/ml)

60

68

0

E.£i2li(0.01 pg/ml)

15

10

0

strains (30 pg/ml)

68-82

V. cholerae (30 us/mli

a : Incubation of toxins and antisera was at 37°C for 30 min and cytopathic changes
recorded after 24 h. Numbers represent % cell rounding for £ . jejuni toxin and % cell
elongation for the toxins of V. cholerae and £. coli.
These results were generated from three separate experiments.
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TABLE 14

ULTRASTRUCTURAL OBSERVATIONS IN INT 407 CELLS
AFTER INOCULATION W ITH THE ETP FROM £ . .IE.IUNI
STRAIN WD 2483

Cell damage
2

Hours post-inoculation
6
12

breakdown of cell and nuclear membranes

-

+

+++

fatty degeneration

+

++

+++

cytoplasmic clearing

+

++

+++

ballooning of nuclear membrane

-

++

+++

mitochondrial damage

++

+++

+++

margination of chromatin

-

+

++

vesiculation

-

++

++

++

+++

blunted microvilli

- = No visual damage; + = Slight; ++ = Moderate; +++ = Extensive

Gold probe was seen attached to the membrane of toxin treated cells irrespective of the time
post treatment
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TABLE IS

LOCATION OF THE ETP AFTER INTERACTION WITH
INT 407 CELLS BY IMMUNOFLUORESCENCE USING
POLYCLONAL OR MONOCLONAL ANTIBODIES

Treatment*

Rationale

Fluorescence

fixed with glutaraldehyde

to immobilize cells

+

fixed with methanol

to make the membranes leaky

+

fixed with glutaraldehyde or methanol

to remove extracellular bound

and treated with trypsin

toxin

fixed with glutaraldehyde or methanol

to probe for both extracellular
and intracellular toxin

and lysed

+

to probe for only intracellular

fixed with glutaraldehyde or methanol,

toxin

treated with trypsin and lysed

*: cells were treated with the ETP for 12 h, fixed as indicated and either exposed to trypsin
and/or lysed
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Figure 6: Bacterial binding of £. jejuni strain WD 2483 to PCEF cells as measured by
viable counts of organisms released from lysed cells/well and by IFA of adherent
organisms/100 cells. For these experiments the average cell number was 2.0 x 106
cells/well. Each well was inoculated with 2.0 x 108 cfu (or at a multiplicity of 100
cfu/cell). The maximum adherence was observed 4 h post-inoculation by both assays and
corresponded to a ratio of 1 cfu/10 eukaryotic cells as measured by viable counts and 1
org/25 eukaryotic cells by IFA. The nonspecific binding of the organisms to the plastic
was 3-4 x 10®cfu/well compared to the 2 x 105 cfu/well that bound to the cells. The data
showed that 0.1% of the inoculum bound to the cells while 1,6-2.0% bound to the plastic.
This indicated that bacterial binding to the plastic occurred at approximately twenty times
higher efficiency than to the host eukaryotic cells. The results are an average of three
separate trials.

70

1

^

2

4
6
time (hour)

cfu/well

H

12

24

36

0rg/100 cells

Figure 7: Bacterial binding of £. jejuni strain WD 2483 to Int 407 cells as measured by
viable counts of organisms released from lysed cells/well and by IFA of adherent
organisms/100 cells. For these experiments the average cell number was 2.0 x 106
cells/well. Each well was inoculated with 2.0 x 108 cfu (or at a multiplicity of 100
cfu/cell). The maximum adherence was observed 4 h post-inoculation by both assays and
corresponded to a ratio of 1 cfu/ 10 eukaryotic cells as measured by viable counts and 1
org/20 eukaryotic cells by IFA. The non-specific binding of the organisms to the plastic
was 3-4 x 10« cfu/well compared to the 2 x 10s cfu/well that bound to the cells. The data
showed that 0.1% of the inocula bound to the cells while 1.6 -2.0% bound to the plastic.
This indicated that bacterial binding to the plastic occurred at approximately twenty times
higher efficiency than to the host eukaryotic cells. The results are an average of three
separate trials.
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using monoclonal antibody
CETPMAb4

a
b
c
using polyclonal antibody

a = outer membrane
b = cytoplasmic membrane
c = cytoplasm + periplasm

Figure 8: Location of the ETP in different fractions of C. ieiuni strain WD 2483. The
outer membrane (a), cytoplasmic membrane (b) and cytoplasm & periplasm (c) fractions
were allowed to adhere to the wells of 96 well microtiter plates and probed with either the
monoclonal antibody, CETPMAb4 specific for the ETP or the polyclonal antibody to strain
WD 2483. The binding of the respective antibodies to the cellular fractions was measured
by ELISA. As is shown in A, CETPMAb4 mainly bound to the outer membrane fraction
whereas the polyclonal antibody showed specificity for all the three fractions as illustrated
in B.

0 .4 n
V. cholerae

Figure 9: Toxin binding of Q. ieiuni strains to GMi ganglioside as measured by ELISA.
The binding of Vibrio cholerae strain 2868 and Escherichia coli strain H10407 are
illustrated as positive controls.
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Figure 10: Binding of £ . ieiuni ETP to PCEF cells as shown by ELISA. The maximum
binding of the toxin to the eukaryotic cells occurred after 2 h incubation. The results are an
average of three separate trials.
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Figure 11: Binding of £ . ieiuni ETP to Int 407 cells as shown by ELISA. The maximum
binding of the toxin to the eukaryotic cells occurred after 2 h incubation. The results are an
average of three separate trials.
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Figure 12: Saturation curve for the toxin binding receptors on PCEF cells. The cells were
grown as confluent monolayers in 96 well microtiter plates and incubated with increasing
concentrations of the ETP for 2 h. The saturation o f the receptors was obtained with 10 ng
o f the toxin.
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Figure 13: Saturation curve for the toxin binding receptors on Int 407 cells. The cells were
grown as confluent monolayers in 96 well microtiter plates and incubated with increasing
concentrations of the ETP for 2 h. The saturation of the receptors was obtained with 10 ng
of the toxin.
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Figure 14: Percent binding of Q. ieiuni ETP to PCEF cells following eukaryotic treatments
as measured by ELISA. Untreated cells gave 100% binding figures as controls. The 50%
reduction point (shown by arrow) was selected as significant Those agents having no
influence on toxin binding included lipid modifiers, lipase and Nonidet P-40; the
carbohydrate modifiers, sodium metaperiodate and B-galactosidase (given above the dotted
line). The proteolytic enzymes trypsin, chymotrypsin, pepsin and protease as well as
glutaraldehyde and neuraminidase (given below the dotted line) all effected a greater than
50% reduction in binding.
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Figure 15: Percent binding of £ . ieiuni ETP to Int 407 cells following eukaryotic
treatments as measured by ELISA. Untreated cells gave 100% binding figures as controls.
The 50% reduction point (shown by arrow) was selected as significant Those agents
having no influence on toxin binding included lipid modifiers, lipase and Nonidet P-40; the
carbohydrate modifiers, sodium metaperiodate and B-galactosidase (given above the dotted
line). The proteolytic enzymes trypsin, chymotrypsin, pepsin and protease as well as
glutaraldehyde and neuraminidase (given below die dotted line) all effected a greater than
50% reduction in binding.
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Figure 16: Competitive binding of £. ieiuni ETP to PCEF cells following coincubation
with sugars, lectins and GMj ganglioside as measured by ELISA. Untreated cells gave
100% binding as controls. The 50% reduction point (shown by arrow) was selected as
significant Except for NurNAc (given below the dotted line), no agent tested significantly
affected toxin binding. The results are an average of three separate trials.
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Figure 17: Competitive binding of Q. ieiuni ETP to Int 407 cells following coincubation
with sugars, lectins and GMi ganglioside as measured by ELISA. Untreated cells gave
100% binding as controls. The 50% reduction point (shown by arrow) was selected as
significant Except for NurNAc (given below the dotted line), no agent tested significantly
affected toxin binding. The results are an average of three separate trials.

81

E
a
o

a

0.0

Figure 18: Location of the toxin in the four cellular fractions of Int 407 cells treated with
the ETP for 12 h. The toxin was detected using the monoclonal antibody, CETPMAb4 in
ELISA tests. The ETP bound to the membrane fraction of the eukaryotic host cells.
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Plate 1 Histological sections of liver tissue from the chick embryo. Hematoxylin and eosin
stain (x 165)
a) normal tissue of 14 day old embryo with dispersed red blood cells; b) liver tissue 5 days
post-inoculation with 100 times the yolk sac LDsoof £ . ieiuni strain WD 2483; c) liver
tissue 1 day post-inoculation intra-yolk sac with bacteria-free filtrate originally containing
5 x 107 cfii/ml of strain WD 2483. Note the congestion (closed arrow) and slight edema
with an absence of inflammatory cells in b and c.
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Plate 2 Histological sections of heart tissue from the chick embryo. Hematoxylin and
eosin stain (x 165)
a) normal tissue of 14 day old embryo; b) heart tissue 5 days post-inoculation with 100
times the yolk sac LDsoof £. ieiuni strain WD 2483; c) heart tissue 1 day post-inoculation
intra-yolk sac with bacteria-free filtrate originally containing 5 x 107 cfu/ml of strain WD
2483. Note the vascular congestion (closed arrow) and edema (open arrow) with an
absence of inflammatory cells in b and c.
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Plate 3 Histological sections of kidney tissue from the chick embryo. Hematoxylin and
eosin stain (x 165)
a) normal tissue of 14 day old embryo showing the well spaced convoluted tubules,
glomeruli and the circulating red blood cells; b) kidney tissue 5 days post-inoculation with
100 times the yolk sac LDso of £. ieiuni strain WD 2483; c) kidney tissue 1 day post
inoculation intra-yolk sac with bacteria-free filtrate originally containing 5 x 107 cfu/ml of
strain WD 2483. Note the congestion of the blood vessels (closed arrow), slight edema
(open arrow) and hemorrhage (long arrow) in b and c. An absence of glomeruli in the
infected tissues and damaged, apparently condensed convoluted tubules were striking.
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Plate 4 Histological sections of spleen tissue from the chick embryo. Hematoxylin and
eosin stain (x 165)
a) normal tissue of 14 day old embryo with dispersed red blood cells; b) spleen tissue 5
days post-inoculation with 100 times the yolk sac LD50 of £ . ieiuni strain WD 2483;
c) spleen tissue 1 day post-inoculation intra-yolk sac with bacteria-free filtrate originally
containing 5 x 107 cfu/ml of strain WD 2483. Note in b and c the congestion (closed
arrow), hemorrhage (long arrow) and an increase in red blood cells dispersed within the
tissue. There was an absence of inflammatory cells in b and c.
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Plate 5 Histological sections of GI tract from the chick embryo. Hematoxylin and eosin
stain (x 165)
a) normal tissue of 14 day old embryo; b) section of the GI tract 5 days post-inoculation
with 100 times the yolk sac LDsoof £ . ieiuni strain WD 2483; c) section of the GI tract 1
day post-inoculation intra-yolk sac with bacteria-free filtrate originally containing
5 x 107 cfu/ml of strain WD 2483. Note the absence of congestion, edema or hemorrhage
in the infected tissue. The treated sections appeared as controls.
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Plate 6 Lane A: non denaturing, discontinuous PAGE of the concentrated dialyzed
bacterial cell-free filtrate of £. jejuni strain WD 2483 showing the eluted toxic protein
(ETP); Lane B: 10% SDS-PAGE of the ETP showing two bands at 65 and 68 kilodaltons;
Lane C: molecular weight markers at 14.3,25.7, 43, 68,97.4 and 200 kilodaltons;
Lane D: western blot of the ETP profile from lane B treated with polyclonal antibody to
strain WD 2483; Lane E: western blot of the ETP profile from lane B treated with the
monoclonal antibody, CETPMAb4-
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Plate 7 Phase contrast microscopic examination of primary chick embryo cells, (x 5280)
a) untreated cell monolayer, b) cells treated with £. ieiuni strain WD 2483 at a multiplicity
of 100 cfu/cell for 12 h. Note the cell rounding, lysis and cellular vacuolation resembling
fatty degeneration.
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Plate 8 Phase contrast microscopic examination of Human Int 407 cells, (x 5280)
a) untreated cell monolayer, b) cells treated with £. jejuni strain WD 2483 at a multiplicity
of 100 cfu/cell for 12 h. Note the cell rounding, lysis and cellular vacuoladon resembling
fatty degeneration.
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Plate 9 Electron micrograph of untreated control Int 407 cells illustrating the principal
organelles in the eukaryotic host cell. Note the prominent golgi complex (arrow) in the
cytoplasm along with numerous mitochondria and a large nucleus.
(x 24,000)
Bar = 1 p m .
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Plate 10 Electron micrograph of Int 407 cells inoculated with £. jejuni strain WD 2483 at a
multiplicity of 100 cfu/cell and incubated for 2 h. Other than a number of membrane
enclosed amorphous-staining bodies (arrow) present in the cytoplasm, the cytology of
these cells appeared relatively normal. Organisms were not evident
(x 27,000)
Bar = lpm.
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Plate 11 Electron micrograph of Int 407 cells inoculated with £. jejuni strain WD 2483 at a
multiplicity of 100 cfu/cell and incubated for 6 h. A number of membrane enclosed
amoiphous-staining bodies occurred in the cytoplasm. Note the membrane lysis (arrow)
and initial damage to the mitochondria. Organisms were not evident
(x 30,600)
Bar = 0.5 pm.
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Plate 12 Electron micrographs of Int 407 cells inoculated with £■ jejuni strain WD 2483 at
a multiplicity of 100 cfu/cell and incubated for 12 h. Cell lysis, cytoplasmic clearing and
margination of the chromatin are shown in both a and b Note an absence of organelles in
a and ballooning of the nuclear membrane (closed arrow) and blunted microvilli (open
arrow) in b. Organisms were not evident.
(a x 28,500; b x 22,800)
Bars = 1 pm.
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Plate 13 Electron micrographs of Int 407 cells inoculated with Q. jejuni strain WD 2483 at
a multiplicity of 100 cfu/cell and incubated for 24 h. Note cell lysis, cytoplasmic clearing,
margination of the chromatin, ghost mitochondria and extensive ballooning of the nuclear
membrane (closed arrow) in a. A majority of the cells were lysed as shown in b.
Organisms were not evident
(a x 12,000; b x 40,000)
Bars = 0.5 pm.

107

108

Plate 14 Scanning electron micrograph of untreated control Int 407 cells showing the
" n o r m a l" surface of the cells. A few clumped cells are those fixed at a stage in cell
division.
(x 2000) Bar = 5 pm.
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Plate 15 Scanning electron micrographs of Int 407 cells treated with £. jejuni strain WD
2483 at a multiplicity of 100 cfu/cell.
a) cells treated for 2 h with the organism; b) cells treated for 6 h with the organism;
c) cells treated with 12 h with the organism; d) cells treated with 24 h with the organism.
Note the progressive changes in the surface of the infected cells with time as the monolayer
loses its integrity. Numerous blebs were seen on the cell surface and cell lysis was
apparent. At no stage of infection were adherent organisms observed.
(a x 1500; b x 2500; c x 2500; d x 2500)
Bars = 5 pm.
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Plate 16 SDS-PAGE (10%) and Western blot transfer of the cellular fractions of Q. ieiuni
strain WD 2483.
Lane a: molecular weight markers in kilodaltons; Lane b: outer membrane fraction
showing ten discemable protein bands. The outer membrane protein profile is dominated
by three bands at molecular weights o f 25.7,43 and 68 kilodaltons; Lane c; protein profile
of the cytoplasmic membrane; Lane d: protein profile of the soluble proteins (cytoplasmic
and periplasmic) showing more than 20 bands; Lane e-h: western blot transfer of soluble
proteins, cytoplasmic membrane, outer membrane and molecular weight markers probed
with the monoclonal antibody, CETPMAh}. Five bands in the outer membrane miction of
approximate molecular weights 20,23, 35,43 and 68 kilodaltons reacted with the
antibody. Interestingly, the monoclonal antibody did not show any antigenic specificity for
the proteins in the cytoplasmic membrane or the soluble protein fraction.
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Plate 17 Electron micrographs of £ . jejuni strain WD 2483 probed for the ETP using
immunogold label.
a) control cells treated with PBS and the gold-conjugated goat anti-mouse serum. No gold
probe particles are evident; b) freeze-thawed £. ieiuni cells treated with the monoclonal
antibody, CETPMAb4 and probed with conjugated goat anti-mouse serum. The organism
was very sensitive to tire freeze-thaw procedure and gold particles were seen attached to the
outer membrane only; c) S-shaped Q . jejuni organism treated with CtsTPMAh* and the
gold conjugated antisera showing the probe attached on the outer membrane.
(a x 80,000; b x 52,500; c x 52,500)
Bars = 0.25 |im.
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Plate 18 Toxic effect on CHO cells treated with ETP and enterotoxins from y. cholerae
and £. coli (100 ng/ml) for 24 h as observed by phase contrast microscopy, (x 3960)
a) untreated control showing confluent cell monolayer, b) cells treated with ETP. Note the
rounding and lysis of affected cells; c) cells exposed to y. cholerae enterotoxin; d) cells
exposed to £. coli enterotoxin. In contrast to the activity of the ETP, cell elongation was
the characteristic feature due to treatment with the enterotoxins of y. cholerae and £. coli.
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Plate 19 Cytotoxic effect of the ETP on primary chick embryo fibroblast cells observed by
phase contrast microscopy (x 5280)
a) untreated control cells; b) cells treated with the ETP for 12 h. Note the cell rounding,
cell lysis and cellular vacuolation resembling fatty degeneration.
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Plate 20 Cytotoxic effect of the ETP on Human Int 407 cells observed by phase contrast
microscopy (x 5280)
.
a) untreated control showing confluent cell monolayer; b) cells treated with the ETP for
12 h. Note the cell rounding and extensive cell lysis.
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Plate 21 Electron micrograph of untreated control Int 407 cells. Note the mitochondria
with their complex membrane structure (closed arrow) and the flattened cistemae of the
endoplasmic reticulum oriented in parallel fashion (open arrow).
(x 24,000)
Bar = 1 pm.
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Plate 22 Electron micrographs of Int 407 cells treated with the ETP for 2 h. The cells were
subsequently treated with the monoclonal antibody, CETPMAb4 and probed with gold
conjugated goat anti-mouse serum.
Note the damage to the mitochondria (open arrow) in both a and b. The initial stages of
cytoplasmic clearing (closed arrow) are apparent in a. The gold particles were attached only
to the cell membrane in the region of the microvilli as shown in b (long arrow).
(a x 32,000; b x 19,200)
Bars = 0.5 pm.
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Plate 23 Election micrographs of Int 407 cells treated with the ETP for 6 h. The cells were
subsequently treated with the monoclonal antibody, CETPMAb4 and probed with gold
conjugated goat anti-mouse serum.
Note die extensive damage to the mitochondria, as well as membrane lysis with extrusion
of the cytoplasm (open arrow) in both a and b. Cytoplasmic clearing and ballooning of the
nuclear membrane (closed arrow) are evident in a and empty mitochondria in b. The gold
probe was seen attached to the membrane surfaces only (long arrow).
(a x 18,000; b x 18,000)
Bars = 1 pm.
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Plate 24 Electron micrographs of Int 407 cells treated with the ETP for 12 h. The cells
were subsequently treated with the monoclonal antibody, CETPMAb4 and probed with
gold conjugated goat anti-mouse serum.
Few surviving membrane bound cells were observed. As shown in a extensive ballooning
of the nuclear membrane (closed arrow), cytoplasmic clearing with empty mitochondria are
evident A majority of the cells were lysed (b) and no longer membrane bound (c). Note
the extrusion of the cytoplasm (open arrow) and ballooning of the nuclear membrane
(closed arrow) along with extensively damaged mitochondria in b. The gold particles were
still seen to be membrane bound and not associated with cytoplasmic
content (long arrow).
(a x 21,600; b x 15,000; c x 21,600)
Bars = 1 Jim.
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Plate 25 Election micrographs of Int 407 cells treated with the ETP for 12 h and freezethawed. The cells were subsequently treated with the monoclonal antibody, CETPMAb4 or
PBS and probed with gold conjugated goat anti-mouse serum.
a represents ETP treated cells which were incubated with PBS (no monoclonal antibody) b
represents ETP treated cells probed with CETPMAb4 and the second conjugated antibody.
Note the membrane lysis, cytoplasmic clearing, margination of the chromatin, empty
mitochondria (open arrow) and ballooning of the nuclear membrane (closed arrow) in both
a and b. At no time w oe any gold particles seen on either of these cells, either membrane
bound or in the cytoplasm.
(a x 14,400; b x 14,400)
Bars = 1 pm.
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Plate 26 Scanning election micrograph of untreated control Int 407 cells showing the
"normal" surface of the cells. A few clumped cells are those fixed at a stage in cell
division.
(x 2000)
Bar = 5 |im.
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Plate 27 Scanning electron micrographs of Int 407 cells treated with the ETP for different
time periods.
a) cells treated for 2 h with the toxin; b) cells treated for 6 h with the toxin; c) & d) cells
treated for 12 h with the toxin. Note the progressive changes in the surface of the infected
cells with time as the monolayer looses its integrity. The toxic effect was evident even at 2
h but by 12 h a majority of the cells were in clumps. Numerous blebs were seen on the cell
surface and cell rounding and lysis was apparent.
(a x 1500; b x 1500; c x 2500; d x 2500)
Bars = 5 Jim.
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Plate 28 SDS-PAGE (10%) and Western blot transfer of the cellular fractions of Int 407
cells treated with the ETP for 12 h.
Lane a: protein profile of the soluble cytoplasmic fraction; Lane b; protein profile of the
membrane fraction; Lane c: protein profile of the nuclei fraction; Lane d: protein profile
of the small granule fraction; Lane e; molecular mass markers in kilodaltons; More than
60 protein bands were present in each of these fractions. Lane f-j: western blot transfer
of the soluble cytoplasmic, membrane, nuclei, small granule fractions and molecular weight
markers probed with the monoclonal antibody, CETPMAba Four bands in the membrane
fraction of approximate molecular weights 32,43,54 and 63 kilodaltons reacted with the
antibody. The monoclonal antibody showed no antigenic specificity for the proteins in the
other three fractions.
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Plate 29 Location of the toxin on Int 407 cells by indirect immunofluorescence.
Glutaraldehyde fixed ETP treated cells were subsequently incubated with monoclonal
antibody CETPMAba and labelled with goat anti-mouse FITC and showed positive
fluorescence as shown in a. Cells treated with ETP, subsequently treated with trypsin to
remove extracellular bound toxin and probed with the primary and secondary antibody
showed no fluorescence shown in b. (x 660)
Similar results were observed in cells probed with the polyclonal antibody.
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Plate 30 Location of the toxin on Int 407 cells by indirect immunofluorescence. Methanol
fixed ETP treated cells were subsequently incubated with polyclonal antibody to strain WD
2483 and labelled with goat anti-rabbit HI'C and showed positive fluorescence as shown in
a. Cells treated with ETP, subsequently treated with trypsin to remove extracellular bound
toxin and probed with the primary and secondary antibody showed no fluorescence shown
in b. (x 660)
Similar results were observed in the cells treated with CETPMAb4

141

INT 407

TOXIN

TOXIN
+

TRYPSIN

Plate 31 Location of the toxin on lysed Int 407 cells by indirect immunofluorescence.
Methanol fixed ETP treated cells were lysed, incubated with polyclonal antibody to strain
WD 2483 and labelled with goat anti-rabbit FITC and showed positive fluorescence as
shown in a. Cells treated with ETP, subsequently treated with trypsin to remove
extracellular bound toxin, lysed and probed with the primary and secondary antibody
showed no fluorescence as shown in b. (x 660) ____
Similar results were observed for cells treated with CETPMAb4
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D ISCUSSION
The pathogenesis of Camnvlohacter iemni has been widely investigated but the
nature of the bacterial virulence factors and the mechanisms by which this organism
initiates enteric disease are not clear. The organism is responsible for the secretory form of
diarrhea seen particularly in children in developing countries but in United States and other
developed countries most cases of Campylobacter enteritis manifest as an inflammatory
process accompanied with fever (26,42,78,100). The presence of non-pathogenic
campylobacteria in the environment may account for the high incidence of asymptomatic
carriage in domestic and wild animals (101) and in humans in developing countries (115).
To date, there has been no suitable animal model for the investigation of the
pathogenic strategies of £ . jejuni. Studies using chickens, mice, pigs, monkeys and calves
have failed to demonstrate a reproducible infection (92,122). Many of these species
appear to be healthy intestinal carriers of £ . jejuni and also constitute reservoirs of the
infection for humans (22,45,107). A suitable model of enteritis would involve animals
that are not asymptomatic carriers but develop signs of the disease after oral inoculation in
similar fashion to humans. With the current pressures to reduce the use of vertebrate
animals in research, it is difficult to get an accurate assessment with large vertebrate animals
as a significant number cannot be tested easily. The fertile hen's egg offers an alternative
useful tool for studying the pathogenesis of this organism at the tissue and cellular levels.
Fertile hens' eggs are relatively easy to handle, inexpensive and can be used in statistically
significant numbers and no specialized facilities are required.
The LD50 studies revealed a high degree of pathogenicity of £ . ieiuni for the
chicken embryo. Relatively few numbers of bacteria were required to achieve these
mortality data and this depicted the highly virulent nature of the organisms for the chick
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embryo. Histopathological examination of the liver, heart, kidney and the spleen following
inoculation with multiple doses of £. jejuni strain WD 2483 revealed congestion of the
blood vessels with slight edema and hemorrhage and a lack of inflammatory cells. No
organisms were detected in any of these organs throughout the course of study. In contrast
to the findings of Field et al. (36), the data in this study indicated that £ . jejuni caused a
non-invasive fatal infection in the chicken embryos. The wide range in the LD50 of £.
ieiuni strains in fertile hens' eggs reported by Field et al. (36) indicated that invasiveness
alone cannot account for the entire spectrum of virulence shown by the organism in this
system. The relative paucity of £. ieiuni isolates from outside the GI tract (142) and the
uniformly negative response of the strains in Sereny test (92) suggest a lack of
invasiveness for this species. Mortality data and histopathological findings in the embryos
were similar for the organism and the bacteria-firee broth filtrates. These findings together
with a lack of organisms in viable counts and IFA studies in the chick embryo organs
suggest a toxic etiology (89). Even though the chick embryo does not mimic the infection
in humans it has proved to be an important tool for assaying the virulence of the organism
and the potency of its toxin.
The role of toxins in the pathophysiology of £. jejuni induced diarrhea is still not
established but it can be speculated that the two pathogenic mechanisms now recognized,
invasion and enterotoxin production, may account in part for the variable clinical pattern of
diarrheal disease caused by this bacterium. However production of a cytotoxin by this
organism has been reported by some workers (48, 111, 161) but its contribution in the
disease process is not clear. Production of a cholera-like enterotoxin by £ . jejuni first
reported by Ruiz-Palacios et al. (124) has gained importance and enterotoxin production
undoubtedly causes the mucus and blood free watery diarrhea often observed in £ . jejuni
infections; this would be particularly so for infections caused by strains lacking invasive
properties. This enterotoxin is thought to behave like the cholera and heat-labile £. soli
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enterotoxins in that it is capable of altering cyclic nucleotide function of intestinal mucosal
cells resulting in pronounced release of fluids into the lumen. On the other hand, the
cytotoxin may be responsible for the inflammatory diarrhea.
Belbouri and Megraud (5) reported 64% of the strains tested to have enterotoxinlike activity while Lindblom et al. (84) reported only 32% of the strains isolated from
humans with acute gastroenteritis and healthy egg laying hens to be toxigenic. It is
possible that failure to identify toxin production in apparently non-toxigenic strains may
reflect variations in storage and growth conditions prior to assay. It has been observed in
other toxin producing organisms that, after several in vitro passages, strains revert to nontoxigenic forms, especially if the toxin production is plasmid-mediated. This may be the
case for £* jeiuni.
A t 68 kilodalton, the molecular mass of the toxin isolated from £ . jeiuni strain WD
2483 was lower than that of cholera toxin (84 kilodalton) or the E- coli heat labile
enterotoxin (91.5 kilodalton), though it approximates the single 70-kilodalton band
reported by McCardell et al. (94) for £ . jejuni. The 65-kilodalton protein band also present
in the ETP lacked toxic activity. The flagellar band at 63 kilodalton demonstrated by many
researchers has been shown to consist of one or several charge trains in 2D electrophoresis
depending on the species (34). It could be quite possible that the protein band observed at
65 kilodalton is the flagellar protein. From embryo protection studies, the toxic activity of
the ETP was neutralized when incubated with CETPMAb4 which showed antigenic
specificity only for the 68-kilodalton protein. Furthermore, the degree of ETP binding to
Int 407 cells as measured by ELISA was the same whether CETPMAtu or the polyclonal
antibody to strain WD 2483 was used. Given that the toxicity of the ETP resided solely
with the 68-kilodalton protein, which did not further cleave in the presence of Bmercaptoethanol, this £ . jejuni toxin, unlike those of Y- cholerae and £. coli. did not
possess subunits. The activity of the ETP was sensitive to heat, acid, alkali and proteases
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but not to lipase suggesting it to be protein in nature (90).
The ability of organisms to adhere to host cells is well documented and it is
generally believed that in enteric pathogens, adherence forms a prelude to initiation of the
disease processes. A number of bacterial components including fimbriae and pili have been
shown to mediate adherence of the bacterium to eukaryotic host cells. The adherence data
of strain WD 2483 using the two cell cultures PCEF and Int 407 cells indicated that a
specific binding interaction between the organism and the host cells either did not exist or
occurred only at very low levels. Bacterial binding of 1 cfu/10 eukaryotic cells by viable
count and approximately 1 org/25 eukaryotic cells for PCEF and 1 org/20 eukaryotic cells
for Int 407 cells by IFA was considered too low to be significant A high non-specific
binding of the organism to the wells of plastic plates was observed at all times. At a
multiplicity of 100 cfu/cell, 0.1% of the inocula bound to the cells while 2% bound nonspecifically to the plastic indicating that the bacterial binding was twenty fold higher for the
plastic than for the eukaryotic cells. No internalized bacteria were found in either cell type,
further confirming the non-invasive nature of strain WD 2483. In contrast to these
findings, McSweegan and Walker (96) reported a high degree of binding of this organism
to Int 407 cells. The cytopathic effects on both PCEF and Int 407 cells were similar in that
the organism caused cell rounding and lysis but the initial stages of the effect were not
observed until 6 h post-inoculation. The organism elicited severe cellular and subcellular
damage to Int 407 cells as revealed by electron microscopy. The ultrastructural damage
was evident at 6 h post-inoculation thus supporting the cytopathic observations made in Int
407 cells using the inverted microscope. The damage to the mitochondria was of a type
typical for toxin treated cells. It is quite possible to assume that this organism resembles £.
coli. in that some strains are enteroinvasive and some toxic in nature with virulence a
multifactorial process.
Using a mouse cecal model, Lee et al. (82) reported that mucus colonization and not
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adherence to the intestinal cells was a determinant for pathogenicity. They did not report
bacterial adherence in the intestinal crypts and wet preparations examined by phase contrast
microscopy showed actively moving £ . ieiuni organisms in the mucus. Whether
organisms adhered to mucus or not was not determined. Mucus penetration in human
infection is undoubtedly facilitated by the spiral shape and darting motility of this organism.
The present data are in accordance with the suggestion of Lee etal. (82) that adherence and
invasiveness of this organism may not be as important a virulence factor as previously
thought. It could be conjectured that in non-adhering or non-invasive strains colonization
of the gut plays a more important role in virulence. As a result of the close association
between the bacteria and the mucosal wall the toxin that the organism produces may bind to
the intestinal cell membranes and thereby exert its activity. Such cytological changes would
then lead to the diarrhea associated with infections due to this organism.
Most bacterial toxins are localized in the periplasm of organisms that produce them.
Studies by Klipstein and Engert (68), McCardeU (94) and Guerrant et al. (48) showed an
increase in toxin production after the cells were treated with polymyxin B which caused a
release of the periplasmic proteins. Interestingly, the Western blots of the different cellular
components of strain WD 2483 probed with the monoclonal antibody CETPMAb4 failed to
show any antigenic specificity for proteins in the cytoplasmic membrane or to the
cytoplasmic and periplasmic fractions. However, 5 bands from the outer membrane
reacted with the monoclonal antibody, and of these one was a major outer membrane
protein previously reported to be a porin (86) and had an approximate molecular mass of 43
kilodalton. The 68-kilodalton protein could be the cytotoxin characterized in this study and
it is quite possible that the toxin is associated with the outer membrane before finally being
secreted into the medium. The other proteins recognized were at 20,23 and 35 kilodaltons.
The Western blot results indicated that the CETPMAhj recognized a very conserved
sequence of the toxin which is exposed in the outer membrane. This sequence may be
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hidden when the toxin is in the cytoplasm or periplasm due to its specific configuration and
is exposed and recognized by the monoclonal antibody only when the toxin is secreted and
attached to the outer membrane due to a change in the spatial arrangement of the toxic
protein molecule. However, it is quite possible that some of the £ . jejuni outer membrane
proteins share a conserved sequence with its cytotoxin which is recognized by this
monoclonal antibody. Production of more monoclonal antibodies to different sequences of
the toxin in similar experiments will further elucidate the location of the toxin in the
organism.
The ELISA tests of the cellular components further support the evidence that a
conserved sequence recognized by the CETPMAh* is present in the outer membrane
fraction of the organism only. However, the polyclonal antibody to strain WD 2483
showed specificity for all the fractions. £. jejuni organisms probed with CETPMAb4 and
gold-conjugated goat anti-mouse antiserum showed the gold probe attached only in a few
sites in the outer membrane of the organism. In freeze-thawed organisms in which some
bacterial cells were subjected to lysis, the probe was only seen attached to the membrane
and at no time inside the cell which confirmed the antigenic specificity of the monoclonal
antibody to protein sequences located either only or preferentially in the outer membrane.
The GMj-ELISA for the detection of enterotoxins from £• coli and Y cholerac
offers a reliable and reproducible method for laboratories without cell culture facilities (4,
126). It is a practical, simple and inexpensive test to detect enterotoxins closely related to
those of E. CQli and Y . cholerae. Since this assay depends on both the attachment of the
toxin to the ganglioside and binding of the antitoxin, preparations positive in these tests
have both the ability to bind to the ganglioside as well as antigenic specificity for the
particular antitoxin used. In other words, if an unknown toxin tests positive in GMiELISA when probed with cholera antitoxin then it can be assumed that the unknown toxin
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was immunologicaUy related to the cholera toxin and may have toxin binding receptors on
the host eukaryotic cells similar to those for cholera toxin. Moreover, the enterotoxin from
Y- cholerae and £. coli produced similar elevations of cyclic AMP and parallel characteristic
morphological changes in CHO cells (47). Studies on the enterotoxin of £ . jejuni by
McCardell e tal. (94) and Johnson and Lior (58), have shown elongation of the CHO cells
similar to that for Y cholerae or £. coli. In contrast to these, the ETP from £ . jejuni strain
WD 2483 did not bind to the GMj ganglioside and induced rounding and lysis of the CHO
cells (90). When the PCEF and Int 407 cells were treated with the ETP, it caused lysis and
rounding of the cells and the cytopathic effect was similar to that observed in the two cell
types treated with strain WD 2483. However, the effect was much faster with the toxin
and was observed at 2 h post treatment compared with similar findings at 6 h post
inoculation with the organism. From these data it would appear that the toxin isolated from
strain WD 2483 differed markedly from the enterotoxins of Y- cholerae. £. coli and that
reported for £. ieiuni by McCardell et al. (94), Ruiz-Palacios et al. (124) and Klipstein and
Engert (68). Furthermore, their lack of immunological relatedness was confirmed by the
absence of cross neutralizing reactivity between ETP and cholera toxin and their respective
antisera. £ . jejuni enterotoxin has been reported to be immunologically and biologically
similar to the cholera toxin (94,124). Indeed, the characterisdcs of the toxin isolated from
strain WD 2483 demonstrated that it was a cytotoxin rather than an enterotoxin (90).
Koga et al. (72) recendy reported leukocidal effects of £ . ieiuni cell-free filtrates on
rabbit leukocytes in vitro. Similarities between the cytotoxin isolated in this study and the
crude cytotoxic filtrates previously reported (48,58,161) include molecular weight, heat
and trypsin sensitivity and CHO cell rounding. However, the toxicity of the ETP was lost
on freeze-thawing but was retained for up to 4 weeks at 4’C and was unaffected by
treatment with polymyxin B.
Most toxins are known to interact with specific receptors on susceptible host cell
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membranes as a prelude to cytoplasmic uptake or initiation of their toxic responses. Others
actually damage the cell membranes. The parameters for both an effective toxin binding
assay and a rationale for determining binding were established. These criteria were used to
characterize the nature of "receptors" on host cells involved in the binding of this cytotoxin.
The toxin binding curves indicated that both PCEF and Int 407 cells carry receptors on their
membranes specific for the cytotoxin and showed maximal binding after 2 h of treatment
followed by rounding and lysis of the host cells with a concomitant decrease in toxin
binding by 24 h. Toxin binding receptors may be delineated on eukaryotic host cells using
specific blocking agents. The process of investigating function through a loss of function
was used to assess the reduction or loss in adherence of the cytotoxin due to inhibitory
agents.
Degradation or immobilization of the eukaryotic cell surface proteins with enzymes
and fixative treatments significantly reduced toxin binding to both the cell types. That
lipase, Nonidet P-40 and fi-galactosidase treatments of the eukaryotic cells did not
significantly reduce binding implied that lipid and lactose moieties do not appear to be
important components in the binding process and therefore an glycolipid-like receptor does
not seem likely. Likewise, treatment of the cell surfaces with sodium metaperiodate did not
adversely affect toxin binding, rather a 5% increase in binding to PCEF cells and a 10%
increase in adherence to Int 407 cells were observed. Even though these values are much
below the 50% mark considered as significant, this observation was very interesting. Of
the mono- and disaccharides tested, none had any effect on toxin binding except for
NurNAc, a parent acid of a family of amino sugars. It accounted fen’a 56.5% reduction in
binding to PCEF and a 50% reduction in binding to Int 407 cells. Treatment of cells with
neuraminidase, a receptor destroying enzyme that liberates N-acetyl neuraminic acid
residues from the cell membranes reduced binding by greater than 90%. However,
commercially available neuraminidase has residual protease activity and this might explain
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the higher reduction in toxin binding as compared to the treatment with protease alone.
From these data it would appear that a simple, single receptor system for the
cytotoxin on the surface of PCEF and Int 407 cells does not occur. A consistently
observed slight increase in binding subsequent to periodate treatment indicated possible
stearic hindrance by a carbohydrate moiety. It is possible that configurational changes after
the oxidation of this moiety led to greater or full exposure of the toxin receptor on the cell
surface thus leading to a slight increase in toxin binding as seen in this study. The
compiled data point towards a surface protein or glycoprotein-like receptor for the
cytotoxin. It may be postulated that the amino-terminal end of NurNAc acts as a receptor
for the £ . jejuni cytotoxin per se. Alternatively, it is possible that the toxin receptor is a
surface protein either linked directly to or acting in consort with a neuraminic acid moiety
(90). Coincubation of the cytotoxin with NurNAc or treatment of the host cell surface with
neuraminidase released the NurNAc residues leading to competitive binding of the
cytotoxin with the free and bound NurNAc moieties. McSweegan and Walker (96) have
shown that the LPS molecules of £. jejuni are involved in the adhesion of the organism to
Int 407 cells and the adherence was reduced in the presence of fucose or mannose. The
presence of these two monosaccharides had no significant effect on the binding of the
cytotoxin. Although the present study does not support the adherence of £ . jejuni to PCEF
or Int 407 cells, it is possible that strain variations exist and some strains possess the
ability to bind to such cells. In cases in which the organisms adhere to eukaryotic cells and
also produce a cytotoxin that binds to host cells, it does not seem unreasonable that the
organism and its toxin would have developed an adherence process using different cell
receptors and thereby avoid competition for the same host cell binding sites. This could
explain differences between the binding process for adherence positive, cytotoxin negative
strains versus adherence negative, cytotoxic positive organisms.
However, one has to be careful in extrapolating the results derived in these
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experimental conditions to those in the clinical situation. Although the Int 407 cells are
epithelial cells derived from the jejunum and ileum of a Caucasian embryo, it is a
transformed cell line. Moreover, the environmental and nutritional differences that exist
between cells propagated in vitro as compared to in vivo conditions may well effect the
expression of eukaryotic host cell receptors. Further studies using purified receptors with
known sequences in similar binding assays could further characterize the specific
components responsible for mediating toxin binding. Elucidation of the receptors and
factors that contribute to the binding of this cytotoxin to host cells will increase our
understanding of the mode of action of this potential virulence trait that may be involved in
the inflammatory diarrhea caused by many £. jejuni isolates.
Ultrastructural damage observed in Int 407 cells treated with the toxin was similar
to the cellular damage observed in the organism treated cells as described previously.
However, the toxin induced damage was much more rapid and the disintegration of the
mitochondria was clearly evident by 2 h post treatment with the toxin as opposed to that
seen after 6 h in the organism treated cells. It is perhaps not surprising to detect a lag
period between the induction of cell damage by organisms, should the histopathologic
changes induced be a direct function of the toxin. By 12 h post-treatment, the few cells that
survived the toxic action of the ETP showed ballooning of the nuclear membrane along
with membrane lysis and clearing of the cytoplasm at the ultrastructural level and confirmed
the potency of this cytotoxin.
Int 407 cells treated with the toxin for various time periods and probed with the
gold-conjugated anti-mouse serum showed irregularly spaced single or small clusters of
particulate gold label only on the cell membranes. At no time was the probe seen inside the
cell or attached to any other cell organelle. Unlike the cytotoxin of Pseudomonas
aeruginosa in which the cytotoxin labelled with colloidal gold attaches to the nuclei and cell
membrane (7), the action of £. jejuni cytotoxin was restricted solely to the cell membranes.
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From the extreme levels of sub-cellular damage, it may be speculated that the response was
due, at least in part, to the lysosomal enzymes released by the action of the cytotoxin.
Western blots of the cellular fractions of Int 407 cells treated with the cytotoxin for 12 h
and probed with the monoclonal antibody showed antigenic specificity for 4 bands in the
membrane fraction only. This further confirmed the membrane binding nature of the
cytotoxin which was further supported by ELISA tests on the cellular fractions. IFA
results on the toxin treated Int 407 cells probed with the polyclonal antiserum to strain WD
2483 indicated that this cytotoxin did not nick itself into A and B subunits as in many other
bacterial toxins. In these the B subunit is responsible for binding while the A subunit
enters the host cell and is responsible for the ultimate toxic effects. If the whole toxin
molecule or a part of it had entered the cells then a negative IFA result using the
CETPMAh* and polyclonal antibody as probes would not be observed with cells treated
with trypsin which removed the adherent toxin but had no effect on the intracellular toxin
molecules. The compiled data demonstrated that the cytotoxin bound to specific receptors
on the host cell membrane, nicked itself and elicited its toxic response by damaging the
membrane as such. This would appear to be the logical conclusion given that the molecular
mass of this cytotoxin was 68 kilodalton but the molecular masses of the proteins in the
membranes to which it was bound were lower than the molecular mass of the whole toxin.
This reduction in weight is possible only if the toxin nicked itself into smaller fragments,
some or all of which retained toxic activity; otherwise the protein bands observed in the
membrane fraction should have a molecular mass higher than 68 kilodalton.
In brief, the results from the present study indicated that the production of a
membrane adhering cytotoxin that bound to protein or glycoprotein-like receptors on host
cell membranes was an important virulence factor in non-invasive strains and may be
responsible for the inflammatory diarrhea caused by many £ . ieiuni strains. The cytotoxin
did not elevate the cyclic adenosine monophosphate content in affected cells as observed
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from the CHO cell assay. It may be postulated that the action of £ . iejuni cytotoxin was
similar to that of Shiga toxin (104) in that it also bound to specific receptors on the
absoiptive cells of the intestine and ultimately led to cell death. As a result diarrhea would
be due to inhibition of absorption rather than active secretion. The loss of microvilli in the
Int 407 cells treated with the cytotoxin in the present study supports this hypothesis.
However, active secretion in the lumen of the intestine is the mode of action for the well
studied enterotoxins of Y- cholerae. £. coli. and is now also the proposed mechanism for
the C. jeiuni enterotoxin induced diarrhea.
Acute diarrheal disease continues to be a major cause of morbidity and mortality
among children in the developing countries as well as a cause of sickness worldwide.
Antimicrobials are not recommended for the alleviation of uncomplicated diarrhea because
of the risk of developing bacterial resistance. Currently, vaccines are being developed for
the other two major enteric pathogens, rotavirus and enterotoxigenic £. coli. These
together with £. jejuni are principally responsible for diarrheal diseases in developing
nations and, if Salmonella species arc added, in developed countries as well. In the case of
Q. jejuni, it seems that toxigenic strains are a significant cause of diarrhea and toxoid-type

vaccines might provide some degree of protection against the enteric disease caused by
them.
Much remains to be determined concerning the precise role of Q. ieiuni cytotoxin in
disease. The wide range of clinical symptoms associated with Campylobacter infections in
humans and animals suggests that there are differences in the response of the host. Even
though the presence of toxins may represent the principal determinant of virulence and the
cause of disease, they may not be the principal determinant of infectivity. Bacteria that
cause disease as a direct result of toxin secretion are usually avirulent when the toxin
gene(s) are removed. In this study the production of a cytotoxin by £ . jejuni indicates that
it is an important virulence factor which may be responsible for influencing the severity of
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Campylobacter enteritis. The location of the genes responsible for toxin production and the
effect of mutants lacking these particular genes on virulence would lead to a better
understanding of the contribution of the cytotoxin in the disease process and ultimately the
organisms.
At present, a variety of methods used for cytotoxin detection include cell cultures
and ELISA tests which are convenient assays for laboratories. However, for large scale
epidemiological surveys, the use of DNA probes may prove to be appropriate. Currently,
it is unknown whether the toxin is plasmid associated or chromosomaUy determined.
Molecular cloning of the toxin genes along with the development of highly specific
monoclonal antibodies would provide powerful tools for the analysis of the structure of the
cytotoxin and the relationship between structure and receptor binding activity as well as the
mechanism(s) for the mode of action of the toxin. Genetically engineered strains of £.
ieiuni that differ only with respect to their toxigenicity or non-toxigenicity would determine
whether the toxin is an essential or accessory virulence factor for primary pathogenesis.
Characterization of the structural genes of the toxin as well as the nucleotide and
corresponding amino acid sequences of their translational products will provide information
on the extent of homology with other known cytotoxins like Shiga toxin and Pseudomonas
exotoxin. Furthermore, the precise post-binding location and orientation of the toxin within
the host eukaryotic cell membranes would eventually decipher its mode of action at the
cellular and molecular levels and eventually lead to the elucidation of the role this potent
cytotoxin plays in the pathogenesis of infection.
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Possible future studies:
This work has revealed a variety of interesting problems, the investigation of which
would extend the available data base on the pathogenesis of £ . ieiuni:
1) sequencing of the 68-kilodalton cytotoxin and raising monoclonal antibodies recognizing
different sequences would further elucidate the location of the toxin within the organism
and its post binding orientation within the host eukaryotic cell membranes;
2) a recycling fermentor could be usefully employed to maximize the production of the
toxin for use in characterization studies, to develop diagnostic detection systems and as a
potential for toxoid vaccine development;
3) location of the gene(s) responsible for cytotoxin production in £ . jeiuni and the
relationship of this toxin to virulence of the organism following mutation or deletion of
these genes;
4) molecular cloning of the toxin producing gene(s) in appropriate bacterial hosts along
with the effect the expression of these cloned genes has on the virulence of the new host
organism;
5) comprehensive characterization of the purified toxin binding receptor on the eukaryotic
cells and the number of specific receptors present on the host cells (especially of intestinal
origin);
6) immune response in an animal model to the heat inactivated toxoid of the cytotoxin for
development of a possible vaccine;
7) role of humoral and cell-mediated immunity in the chick embryo to £. jejuni infection in
the face of bacterial challenge;
8) role of enterotoxin production, cytotoxin production and invasiveness of the different
strains of the organism in the overall pathogenesis of disease.
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APPENDICES
APPENDIX 1
1. Reagents used in histological studies
1.1 Hematoxylin solution
Hematoxylin crystals

5g

Absolute alcohol

50 ml

Aluminum ammonium sulfate

100 g

1000 ml

De-ionized water
Mercuric oxide

25 g

The hematoxylin crystals were dissolved in alcohol and mixed rapidly with aluminum
ammonium sulfate dissolved in water and brought to the boil. Mercuric oxide was then
added slowly and the mixture reheated for 20 min. This was transferred to glass coplin jars
ready for use.
1.2 Eosin solution
10 grams of eosin was added into a liter of de-ionized water and 2 ml of glacial
acetic acid was added to the mixture. This stock solution was stared at 20*C. A working
solution was made by mixing 50 ml of the stock solution with 120 ml absolute alcohol, 30
ml de-ionized water and 1 ml glacial acetic acid.
1.3 Acid alcohol solution
This was made by adding 70% alcohol (710 ml of 95% alcohol in 290 ml de
ionized water) to 10 ml concentrated hydrochloric acid. The solution was stored at 20‘C.
1.4 Saturated lithium carbonate
4.5

grams of lithium carbonate was dissolved in 450 ml of de-ionized water and

stored in a stoppered bottle at room temperature.
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1.5 Buffered formalin solution

A 10% formalin solution was made in PBS by adding 27 ml of formalin (37%) to
173 ml of PBS and stored in stoppered bottles.

1.6 Procedure for hematoxylin and eosin staining
Histoclear (2 changes)

2min

100% alcohol (2 changes)

1min

95% alcohol (2 changes)

1min

De-ionized water

3dips

Hematoxylin

6min

Running water

2min

Acid alcohol

8dips

De-ionized water

3dips

Lithium carbonate

7dips

Running water

15min

Eosin

4min

95% alcohol (2 changes)

15 sec

100% alcohol (2 changes)

15 sec
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APPENDIX.. 2
2. Media used in cell cultures
2.1

pg-ioniacd water
The water used in cell culture studies was obtained from a Millipore Milli Q

filtration unit Ten megaohm water was collected, filter sterilized through a 0.2 pm pore
size filter and stored in sterile bottles at 4'C.
2.2 Sodium bicarbonate (NaHCCM
A 7.5% solution of sodium bicarbonate (Sigma) was made by dissolving 7.5 grams
of NaHCOj in 100 ml of de-ionized water and filter sterilized applying positive pressure
through a 0.2 pm filter. The solution was stored in sterile bottles at 4*C.
2.3 Phosphate buffered saline (PBS)
PBS was made by dissolving 8 grams of NaCl, 0.2 grams of KG, 0.2 grams of
KH2PO4 and 0.15 grams Na2HP04 in a liter of de-ionized water. It was sterilized by
autoclaving and stored at 4*C.
2.4 Glutamine
The lOOx stock solution of glutamine (200 mM) (Sigma) was made by dissolving
2.92 grams of glutamine in 100 ml of de-ionized water and filter sterilized. It was stored in
sterile bottles at -20*C.
2.5 Hank's Balanced Salt Solution (HBSS)
A lOx stock solution of HBSS with phenol red was obtained from Irvine Scientific.
The stock solution was diluted ten fold under aseptic conditions with sterile de-ionized
water. Sterile NaHCC>3 (0.35 g/1) was added and the solution stored in sterile bottles at
4*C.
2.6 Minimum essential media (MEM)
A lOx stock solution of MEM with non-essential amino acids was obtained from

178

Irvine Scientific. The concentrated solution was diluted ten fold with sterile de-ionized
water and stored at 4*C.
2.7 Trvpsin-EDTA
Trypsin-EDTA solution was made by dissolving 0.5 grams of trypsin (Sigma) and
0.2 grams of EDTA (Sigma) in a liter of PBS. The solution was filter sterilized through a
0.2 pm filter and stored in sterile bottles at 4*C.
2.8 Serum

New bom calf serum (Sigma) and Fetal bovine serum (Irvine Scientific) were
distributed in 50 ml aliquots in sterile plastic tubes and stored at -20*C.
2.9 Growth medium
MEM

450 ml

Serum

50 ml

NaHCQj (7.5%)

10 ml

Glutamine (200 mM)

0.5 ml

2.10 Maintenance medium
The maintenance media was prepared the same way as the growth media except that
the serum concentration was reduced to 1%.
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APPENDIX 3
3. M edia and p rocedure used for preparing M onoclonal antibodies

3.1 Serum free medium (SFM1
RPM I1640 with NaHCQ} (Irvine Scientific)

990.0 ml

L - Glutamine (200 mM)

10.0 ml

The media was stored in sterile glass bottles at 4*C.
3.2 HAT medium
lOOx thymidine (1.6 mM) was made by dissolving 38.8 mg of thymidine in serum
free medium.
lOOOx aminopterin (0.08 mM) was made by dissolving 3.5 mg of aminopterin in
100 ml of sterile double distilled water.
lOOx hypoxanthine (10 mM) was made by dissolving 136 mg hypoxanthine in 100
ml of serum free medium. The solution was put in a shaking water bath at 70‘C for 3 h.
All three solutions were filter sterilized and kept in sterile bottles.
Serum free medium

879.0 ml

Fetal bovine serum (heat inactivated)

100.0 ml

100 x hypoxanthine

10.0 ml

1000 x aminopterin

1.0 ml

100 x thymidine

10.0 ml

The media were made under aseptic conditions and gloves were worn when handling this
media. It was stored in sterile bottles at 4*C.
3.3 Polyethylene elvcol (PEG) preparation
PEG (mol. wt. 4000) was obtained from Sigma. 10 grams of it was placed in a
screw cap tube and autoclaved for 20 min. Serum free medium (18.4 ml) was warmed to
56*C and 1.6 ml of DMSO was added to it. This mixture was filter sterilized. The
autoclaved PEG was cooled to 70*C and the Serum free medium-DMSO mixture was
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added to it. This was stored at 4*C until needed.
3.4 2x Phosphate buffered saline (PBS1
PBS was made by dissolving 8 grams of NaCl, 0.2 grams of KG, 0.2 grams of
KH2PO4 and 0.15 grams Na2HPC>4 in 500 ml of de-ionized water. It was sterilized by
autoclaving and stored at 4*0.
3.5 Macrophage collection
Two female Balb/c female mice were injected intraperitoneally with 2 ml of sterile
thioglycolate broth. After 4 days, the mice were cervically dislocated and their abdomens
were sprayed with 70% alcohol. With a 18 G needle, 10 ml of SFM was injected into the
abdomen of each mouse. The SFM was expelled and aspirated carefully out of the
abdomen three times to collect as many peritoneal cells as possible. The cell suspension
was placed in a 50 ml tube and centrifuged at 400 x g for 5 min. The pellet was
resuspended in 0.3 ml of SFM and 5 ml of sterile de-ionized water was added to lyse the
red blood cells. Immediately, 5 ml of 2x PBS was added and the suspension was
centrifuged again at 400 x g for 5 min. The pellet was suspended in 10 ml of HAT medium
and the macrophage concentration adjusted to 3 x 105 cells/ml. Using 96 well plates, 0.1
ml of the macrophage preparation was dispensed into the wells a day before the fusion.
3.6 Spleen preparation
The spleen from the primed mouse was removed aseptically and placed in a sterile
petri dish containing 3 ml of SFM. The connective tissue was removed and the spleen was
injected with SFM using a 25 G needle so as to remove the red blood cells from the
sinusoids. The spleen was then transferred to another petri dish with 2 ml of SFM and cut
into small fragments. The suspension was aspirated and expelled using a 18 G needle to
get individual cells of the spleen tissue. The spleen suspension was then transferred into a
sterile 50 ml conical tube and centrifuged at 450 x g for 5 min. The pellet was resuspended
in 0.3 ml of SFM and 5 ml of sterile de-ionized water was added to lyse the red blood cells.
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Immediately, 5 ml of 2x PBS was added and the suspension was centrifuged again at 450 x
g for 5 min. The pellet was then suspended in 10 ml of SFM and centrifuged again at 450
x g for 3 min. The resultant pellet was again suspended in 5 ml of SFM and the number of
cells counted. The spleen cells were now ready for fusion.
3.7 NS-1 cell preparation
The NS-1 cells were obtained from the freezer at -70*C two weeks before the
fusion. They were thawed at 37’C in a water bath and transferred to a 75 cm2 flask
containing the SFM with 10% fetal bovine serum. The flask was incubated at 37*C in a
CO2 incubator. When a confluent layer was formed the cells were split into three flasks
and reincubated. On the day of the fusion 8 flasks of NS-1 cells were ready to be fused
with the spleen cells. The cells were suspended in SFM in a 50 ml tube and centrifuged at
450 x g for 3 min. The pellet was resuspended in SFM and washed three times by
centrifuging. After the washing the cells were suspended in SFM and counted.
Approximately 6 x 107 NS-1 cells were mixed with 108 spleen cells and centrifuged
at 450 x g for 5 min.
3.8 Eusion
The PEG preparation was warmed in a 37*C water bath. Using a 1 ml pipette, 1 ml
of PEG prep was added to the pellet (containing both cell types) over a 1 min period with
stirring. Next a 25 ml pipette was filled with SFM and 1 ml was added slowly over a 1
min period, 3 ml over the next minute and the remaining 16 ml was added over the course
of another minute. The suspension was centrifuged at 450 x g for 5 min. The supernatant
was removed and 10 ml of HAT medium was added to wash the residual PEG slowly so as
not to disturb the pellet. The media was removed and the pellet was suspended in 1 ml of
HAT medium over a period of 1 min and slowly another 9 ml were added. The
suspension was added in a T-75 cm2 flask containing 10 ml of HAT medium and incubated
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at 37'C for 2 h. The fusion mixture was then diluted 1:10 and 0.1 ml was distributed
carefully in the 96 well plates which were coated with the macrophage feeder layer, a day
before. The final cell concentration was approximately 5 x 104 cells/well.
The plates were left undisturbed in the incubator for 4 days post fusion. At this
time the medium in the wells was changed. Thereafter, fresh medium was added every 2-3
days and the cells were maintained in HAT medium for 18 days. Positive wells were
identified as white 'spotches' in the bottom of a well, using a microtiter mirror. The wells
positive for antibody production were transferred to 24 well plates, then 6 well plates and
subsequently to T-75 cm2 flasks. The hybridomas were then frozen at -70’C.
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APPENDIX 4
4. Reagents used in enzyme-linked immunosorbent assay (ELISA)
4.1 10x Phosphate buffered saline (PBS)
Sodium Phosphate (monobasic)

7.73 g

Sodium Phosphate (dibasic)

20.44 g

Sodium chloride (0.15 M)

87.66 g

Distilled water

1000 ml

The stock solution was stored at room temperature. Before use, it was diluted ten-folds in
distilled water.
4.2 T-PBS (washing buffer^
To a lx solution of phosphate buffered saline (pH 7.3), 0.5 % (v/v) of Tween-20 (BioRad)
was added to make the washing buffer. It was made fresh before each use.
4.3 Post Coat Buffer
Bovine Serum Albumin (BSA)

30.0 g

lx PBS (pH 7.3)

1000ml

The post coat buffer was aliquoted in 50 ml tubes and stored at -20*C.
4.4 Horseradish peroxidase conjugate
The conjugates, both goat anti-rabbit and goat anti-mouse were obtained from
Organon Teknika Corp. For ELISA these were diluted to 1:8000 in lx PBS (pH 7.3) and
0.1 ml added to each of the wells of 96 well plates for 1 h at 37'C.
4.5 Peroxidase substrate buffer
Sodium acetate (trihydrate)

13.6 g

Distilled water

1000 ml

The pH was adjusted to 4.9 by adding solid citric acid, monohydrate. The buffer was
stored in glass bottles at 4*C.
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4.6 3,3’. 5.5'- Tetramethyl Benzidine (TMB) solution
TMB (42 mM)

100 mg

Methyl Sulfoxide

10 ml

Both TMB and methyl sulfoxide were obtained from Sigma. The solution was stored in
the dark at room temperature.
4.7 TMB Substrate
The substrate mixture was prepared by adding 1.0 ml of TMB solution dropwise
with gentle swirling to 100 ml of peroxidase substrate buffer followed by 14.7 |il of 30%
H2O2. The substrate was prepared immediately before use. The reaction was stopped by
adding 0.1 ml of 2 M sulfuric acid.
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APPENDIX 5
5. R eagents used in polyacrylam ide gel electrophoresis and Im m unoblotting

Non-denaturine discontinuous gels
5.1 Lower tank buffer (p H 7.471
Tris (63 mM)

30.27 g

IN HQ (50 mM)

200ml

De-ionized water

4000 ml

5.2 Upper tank buffer fpH 8.891
Tris (37.6 mM)

4.56 g

Glycine (40 mM)

3.0 g

De-ionized water

1000 ml

5.3 Separating gel buffer (pH 8.481
Tris (1 M)

11.47 g

IN HC1 (0.289 mM)

28.92 ml

De-ionized water

100 ml

5.4 Monomer solution for separating pel (40%T 5%C1
Acrylamide

38.00 g

Bis

2.00 g

De-ionized water

100 ml

The monomer solution was kept in a screw capped bottle wrapped with aluminum foil at
4*C
5.5 Catalyst
Ammonium persulfate

0.06 g

Riboflavin phosphate (0.02%)

10 ml

De-ionized water

100 ml

The catalyst was kept in a screw capped bottle wrapped with aluminum foil at 4*C
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5.6 Separating gel ( 10%T 5%C)

Monomer solution

7.50 ml

Separating buffer

7.50 ml

De-ionized water

3.75 ml

Catalyst

3.75 ml

T

20 ill

The mixture was degassed in a 50 ml side arm vacuum flask in the dark before adding
TEMED. The gel was polymerized by illuminating them with a light box.
5.7 Stacking pel (5%)
The stacking gel was made the same way as for SDS gels (given in 3.15) except
that the SDS was not incorporated in the mixture.
Sodium dodecvl sulfate (SDS) eels
5.8 Laemmli running buffer (lOx)
Tris

30.0g

Glycine

144.2g

SDS

10.0g

De-ionized water

1000ml

The buffer was stored in glass bottles at room temperature and was diluted ten fold with de
ionized water before use.
5.9 Laemmli a c rv la m id e

solution

Acrylamide (30%)

60 g

Bis (0.8%)

1.6 g

De-ionized water

200 ml

The solution was filtered through a 0.45 pm filter and stored in a screw capped glass bottle
wrapped with aluminum foil at 4*C. Acrylamide is neurotoxic and was always handled
with care.
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5-10 IM T ris fpH 6.81

A one-molar solution of tris was made by dissolving 121.1 grams of tris in 800 ml
of de-ionized water and the pH was adjusted to 6.8 with HC1. The volume was then
brought up to 1000 ml with water and stored in glass bottles at room temperature.
5.11

IMTris (pH8.8)
A one-molar solution of tris was made by dissolving 121.1 grams of tris in 800 ml

of de-ionized water and the pH was adjusted to 8.8 with HO. The volume was then
brought up to 1 liter with water and stored in glass bottles at room temperature
5.12 SDS (20%)
A solution of 20% SDS was made by dissolving 50 grams of SDS in 250 ml of de
ionized water. It was filtered through a 0.45 pm filter and the solution was stored in a
glass bottle at room temperature.
5.13 Ammonium persulfate (10%)

The solution was made by dissolving 50 mg of ammonium persulfate in 500 pi of
distilled water. It was stored at 4*C and made fresh every four to five days.
5.14 Separating gel (10%)
1 M Tris (pH 8.8)

11.2 ml

20% SDS

150 pi

Acrylamide

10.0 ml

De-ionized water

8.7 ml

10% ammonium persulfate

100 pi

TEMED

20 pi

The mixture was degassed for 20 min before adding ammonium persulfate and TEMED
5.15 Stacking gel (5%)
1 M Tris (pH 6.8)

1.25 ml

20% SDS

50 pi
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Acrylamide

1.67 ml

De-ionized water

7.03 ml

10% ammonium persulfate

50 pi

TEMED

10 pi

The mixture was degassed for 20 min before adding ammonium persulfate and TEMED.
5.16 Non-denaturing non-reducing sample buffer
1 M Tris (pH 6.8)

8 ml

Glycerol

10 ml

De-ionized water

82 ml

The buffer was stored at 4*C in a sterile screw cap glass bottle.
5.17 Non-reducing sample buffer

1 M Tris (pH 6.8)

8 ml

Glycerol

10 ml

20% SDS

10 ml

De-ionized water

72 ml

The buffer was stored at 4*C in a sterile screw cap glass bottle.
5.18 Reducing sample buffer
1 M Tris (pH 6.8)

8.0 ml

Glycerol

10.0 ml

20% SDS

10.0 ml

&-mercaptoethanol

4.8 ml

De-ionized water

67.2 ml

The buffer was always made in a fume hood and stored at 4’C in a sterile screw cap glass
bottle.
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Solutions for Immunoblotting
5.19 lQx Tris buffered saline (TBS1
Tris (20 mM)
NaQ (500 mM)

24.2 g
292.4 g

De-ionized water

1000 ml

Before use the stock solution was diluted ten fold with water.
5.20 Tween 20-TBS (T-TBS1
It was made by adding 0.5 ml of Tween-20 to 1 liter of a lx solution of TBS fresh
before use.
5.21 Blocking solution
Gelatin
TBS (lx)

3.0 g
100 ml

5.22 Antibody buffer
Gelatin
TBS (lx)

1.0 g
100 ml

5.23 HRP color development solution
It was made firesh just before use. 60 mg of HRP color development reagent (4chloro-l-naphthol) (BioRad) was added to 20 ml of ice cold methanol. This mixture was
added to 60 pi of H2O2 (30%) in 100 ml of TBS at room temperature and was ready for
use.
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APPENDIX 6
6.

R eagents used in Electron M icroscopy

6.1 Grids
Copper grids (400 mesh) were used and were supplied by Electron Microscopy
Sciences (EMS).
6.2 Cacodvlate buffer
A 0.1 M buffer was made by dissolving 21.4 grams of sodium cacodylate (EMS) in
a liter of double distilled water while 0.05 M was made by dissolving 10.2 grams in a liter
of double distilled water The pH was adjusted to 7.3 using hydrochloric acid and the
buffer was filtered through a 0.2 jxm filter and was stored at 4‘C.
6.3 Glutaraldehvde
Glutaraldehyde was obtained from EMS grade 50% (v/v) aqueous solution. A
working solution of 5% (v/v) was made in cacodylate buffer as required.
6.4 Osmium tetroxide
A 2% (w/v) stock solution of osmium tetroxide (Stevens Metallurgic Corporation)
was made by dissolving a 1 g ampule in 50 ml of cacodylate buffer. It was always handled
in a fume hood. The solute dissolved after standing overnight at 4'C and the solution was
stored at the same temperature in a tightly capped bottle covered with aluminum foil. The
working solution (1%) was made in cacodylate buffer before use.
6.5 Ethanol series
A graded ethanol series was made by mixing appropriate amounts of absolute
alcohol and double distilled water. The 50% and 70% ethanol was stored at 4*C while the
90% and 95% were stored at room temperature. Absolute alcohol was stored in a
desiccator at room temperature.
6.6 Epoxy, propane (propylene oxide)
This was obtained from EMS and supplied ready for use. It was always kept in
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tightly stoppered containers.
6.7 Enon-Araldite resin mixture

The resin mixture was made from the following components in the following proportions
Epon 812 (resin)

5 parts

Dodecenyl succinate anhydride (DDSA)

11 parts

Araldite (resin)

3 parts

Dibutyl phthalate (plasticizer)

0.8 parts

DMP-30 (accelerator)

0.4 parts

The components were added in the above order with the exception of DMP-30 and shaken
vigorously. The accelerator was added just before the resin was to be used and properly
mixed.
Stains for thin sections
6.8 Uranvl acetate
A 3% (w/v) solution of uranyl acetate was made by dissolving 1 g in 20 ml of
double distilled water. The solution was left overnight at room temperature to dissolve the
uranyl acetate. It was filtered through a 0.2 pm filter and stored in a dark stoppered bottle
at room temperature.
6.9 Lead citrate
A pellet o f sodium hydroxide was dissolved in 15 ml of boiled cooled double
distilled water and 0.1 g of lead citrate was added to it It was mixed to dissolve the lead
citrate and distilled water (boiled cooled) was added to bring the volume to 25 ml. The
stain was stored in tightly screw capped bottle at room temperature.
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Embedding of specimens for electron microscopy
Procedure

Time

1. Wash in cacodylate buffer

15 min

2. Fix in 5% glutaraldehyde in cacodylate buffer

60 min

3. Wash in cacodylate buffer (ten changes)

45 min

4. Post-fix in 1% osmium tetroxide

60 min

5. Wash in cacodylate buffer

5 min

6. Dehydrate in ethanol series

20 min

7. Complete dehydration in absolute alcohol
and propylene oxide

40 min

8. Resin / epoxy propane mixture

120 min

9. Resin (two changes)

120 min

10. Polymerization

24 h

Total time required

Approximately 32 h
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